HOYA Corporation and its Subsidiaries

Consolidated Financial Statements under IFRSs

and Independent Auditor's Report

For the year ended 31 March 2020

HOYA Corporation

Note:

This is an excerpt translation of the "Yukashoken-Houkokusho" for the convenience of oversea stakeholders.

In cases where any differences occur between the English translation and the Japanese original, the Japanese original shall prevail.

Contents

Independent Auditor's Report.....................................................................................................................................

3

Consolidated Statement of Financial Position............................................................................................................

6

Consolidated Statement of Comprehensive Income...................................................................................................

8

Consolidated Statement of Changes in Equity............................................................................................................

10

Consolidated Statement of Cash Flows.......................................................................................................................

15

Notes to the Consolidated Financial Statements.........................................................................................................

17

1 General information.....................................................................................................................................

17

2 Basis of consolidated financial statements..................................................................................................

18

3 Significant accounting policies....................................................................................................................

20

4 Critical accounting judgements and key sources of estimation uncertainty................................................

34

5 Operating segment information...................................................................................................................

35

6 Property, plant and equipment.....................................................................................................................

40

7 Leases..........................................................................................................................................................

44

8 Goodwill and intangible assets....................................................................................................................

47

9 Impairment losses........................................................................................................................................

50

10 Investments in associates.............................................................................................................................

53

11 Deferred taxes and income taxes.................................................................................................................

54

12 Other financial assets and liabilities............................................................................................................

59

13 Other assets and liabilities...........................................................................................................................

61

14 Inventories...................................................................................................................................................

62

15 Trade and other receivables.........................................................................................................................

62

16 Interest-bearing debt....................................................................................................................................

63

17 Retirement benefit plans..............................................................................................................................

65

18 Provisions....................................................................................................................................................

69

19 Trade and other payables.............................................................................................................................

70

20 Share capital and other equity items............................................................................................................

71

21 Financial instruments...................................................................................................................................

75

22 Share-based payments..................................................................................................................................

91

23 Revenue........................................................................................................................................................

94

24 Revenue and expenses (excluding finance income and costs).....................................................................

96

25 Finance income and costs............................................................................................................................

98

26 Other comprehensive income......................................................................................................................

99

27 Earnings per share.......................................................................................................................................

101

28 Non-cash transactions..................................................................................................................................

102

29 Subsidiaries..................................................................................................................................................

103

30 Related party disclosures.............................................................................................................................

110

31 Business combinations.................................................................................................................................

112

32 Contingent liabilities....................................................................................................................................

112

33 Commitments for expenditure.....................................................................................................................

112

34 Subsequent events........................................................................................................................................

112

35 Approval of financial statements.................................................................................................................

113

- 2 -

INDEPENDENT AUDITOR'S REPORT

To the Board of Directors of HOYA CORPORATION:

Opinion

We have audited the consolidated financial statements of HOYA CORPORATION and its subsidiaries (the "Group"), which comprise the consolidated statement of financial position as of March 31, 2020, and the consolidated statement of comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies, all expressed in Japanese yen.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of March 31, 2020, and its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with International Financial Reporting Standards ("IFRSs").

Convenience Translation

Our audit also comprehended the translation of Japanese yen amounts into U.S. dollar amounts and, in our opinion, such translation has been made in accordance with the basis stated in Note 2 to the consolidated financial statements. Such U.S. dollar amounts are presented solely for the convenience of readers outside Japan.

Basis for Opinion

We conducted our audit in accordance with auditing standards generally accepted in Japan. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the provisions of the Code of Professional Ethics in Japan, and we have fulfilled our other ethical responsibilities as auditors. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Responsibilities of Management and the Audit Committee

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with IFRSs, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern in accordance with IFRSs and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

The Audit Committee is responsible for overseeing the Officers and Directors' execution of duties relating to the design and operating effectiveness of the controls over the Group's financial reporting process.

Auditor's Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with auditing standards generally accepted in Japan will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with auditing standards generally accepted in Japan, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks. The procedures selected depend on the auditor's judgement. In addition, we obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

- 3 -

  • Obtain, when performing risk assessment procedures, an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group's internal control.
  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
  • Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group to cease to continue as a going concern.
  • Evaluate whether the overall presentation and disclosures of the consolidated financial statements are in accordance with IFRSs, as well as the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
  • Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.

We communicate with the Audit Committee regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide the Audit Committee with a statement that we have complied with relevant ethical requirements regarding independence, and communicate with it all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

- 4 -

Interest Required to Be Disclosed by the Certified Public Accountants Act of Japan

Our firm and its designated engagement partners do not have any interest in the Group which is required to be disclosed pursuant to the provisions of the Certified Public Accountants Act of Japan.

23 June 2020

- 5 -

Consolidated Statement of Financial Position

HOYA Corporation and its Subsidiaries

As at 31 March 2020

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

Notes

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

ASSETS

NON-CURRENT ASSETS:

Property, plant and equipment-net

6,9,33

111,077

152,302

1,399,448

Goodwill

8,9

42,843

42,082

386,677

Intangible assets

8,33

44,308

39,796

365,667

Investments in associates

10

349

1,007

9,250

Long-term financial assets

12,21

44,103

45,975

422,448

Other non-current assets

13

2,960

685

6,297

Deferred tax assets

11

10,162

7,990

73,415

Total non-current assets

255,802

289,836

2,663,203

CURRENT ASSETS:

Inventories

14

78,973

78,130

717,910

Trade and other receivables

15,21

110,847

103,339

949,547

Other short-term financial assets

12,21

3,131

1,303

11,976

Income taxes receivable

820

510

4,687

Other current assets

13

20,946

19,907

182,918

Cash and cash equivalents

21

293,397

317,982

2,921,820

Total current assets

508,113

521,171

4,788,857

Total assets

763,915

811,008

7,452,060

- 6 -

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

Notes

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

EQUITY AND LIABILITIES

EQUITY

Share capital

20(1)

6,264

6,264

57,560

Capital reserves

20(1)

15,899

15,899

146,087

Treasury shares

20(2)

(8,319)

(27,963)

(256,945)

Other capital reserves

20(2),22

(7,434)

(8,428)

(77,442)

Retained earnings

20(3),34

617,459

676,058

6,212,056

Accumulated other comprehensive income/(loss)

(713)

(16,788)

(154,257)

Equity attributable to owners of the Company

623,155

645,042

5,927,058

Non-controlling interests

20(4)

4,552

(15,777)

(144,968)

Total equity

627,707

629,265

5,782,090

LIABILITIES

NON-CURRENT LIABILITIES:

Interest-bearinglong-term debt

7,16,21

904

14,472

132,977

Other long-term financial liabilities

12,21

10,936

23,923

219,817

Retirement benefit liabilities

17

2,770

3,203

29,428

Provisions

18

2,607

2,539

23,327

Other non-current liabilities

13

2,303

1,363

12,526

Deferred tax liabilities

11

4,917

3,851

35,386

Total non-current liabilities

24,436

49,350

453,461

CURRENT LIABILITIES:

Interest-bearingshort-term debt

7,16,21

1,934

7,494

68,857

Trade and other payables

19,21

54,887

62,895

577,922

Other short-term financial liabilities

12,21

646

2,824

25,944

Income tax payables

8,872

17,765

163,235

Provisions

18

1,261

1,234

11,342

Other current liabilities

13

44,171

40,181

369,209

Total current liabilities

111,772

132,393

1,216,509

Total liabilities

136,208

181,743

1,669,970

Total equity and liabilities

763,915

811,008

7,452,060

- 7 -

Consolidated Statement of Comprehensive Income

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020

Continuing operations

Revenue:

Sales

Finance income

Other income

Total revenue

Expenses:

Changes in goods, products and work in progress

Raw materials and consumables used

Employee benefits expense

Depreciation and amortisation

Subcontracting cost

Advertising and promotion expense

Commissions expense

Impairment losses

Finance costs

Share of loss of associates

Foreign exchange (gain)/loss ,net

Other expenses

Total expenses

Profit before tax

Income tax expense

Profit for the year from continuing operations

Profit for the year

Other comprehensive income/(loss):

Items that will not be reclassified subsequently to profit or loss:

Financial assets measured at fair value through other comprehensive income

Remeasurements of the net defined benefit asset and liability, net Income tax relating to components of other comprehensive income/

(loss) Subtotal

Items that may be reclassified subsequently to profit or loss: Exchange differences on translation of foreign operations Share of other comprehensive income of associates

Income tax relating to components of other comprehensive income Subtotal

Total other comprehensive income/(loss) Total comprehensive income/(loss) for the year

(Thousands of

(Millions of Yen)

(Millions of Yen)

U.S. Dollars (Note

2))

For the year ended

For the year ended

For the year ended

Notes

31 March 2020

31 March 2020

31 March 2019

23

565,810

576,546

5,297,677

25

2,773

3,461

31,806

24

3,775

2,463

22,627

572,359

582,470

5,352,111

(2,763)

1,003

9,215

86,977

93,381

858,042

17,22,24

132,006

133,734

1,228,834

6,7,8,24

26,416

34,374

315,848

5,376

4,657

42,796

12,719

12,214

112,231

24

34,051

33,723

309,865

9

1,099

300

2,760

7,17,25

391

791

7,264

10

1,113

1,652

15,182

24

2,307

1,606

14,755

6,7,8,24

128,010

117,768

1,082,127

427,702

435,202

3,998,919

144,657

147,268

1,353,192

11

22,584

32,681

300,295

122,072

114,587

1,052,898

122,072

114,587

1,052,898

26

809

933

8,570

17

(293)

(50)

(463)

11

(146)

(212)

(1,949)

371

670

6,158

6,612

(16,806)

(154,420)

10

(16)

76

701

11

124

(203)

(1,863)

6,720

(16,932)

(155,583)

7,091

(16,262)

(149,424)

129,164

98,325

903,473

- 8 -

Profit attributable to:

Owners of the Company

Non-controlling interests

Total

Total comprehensive income/(loss) attributable to: Owners of the Company

Non-controlling interests Total

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

For the year ended

For the year ended

For the year ended

Notes

31 March 2020

31 March 2020

31 March 2019

122,103

114,406

1,051,239

(31)

181

1,659

122,072

114,587

1,052,898

129,334

98,364

903,833

(171)

(39)

(360)

129,164

98,325

903,473

(Yen)

(Yen)

(U.S. Dollars (Note

2))

Notes

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Basic earnings per share

27

Continuing operations

321.55

303.27

2.79

Discontinued operations

Basic earnings per share

321.55

303.27

2.79

Diluted earnings per share

27

Continuing operations

320.96

302.74

2.78

Discontinued operations

Diluted earnings per share

320.96

302.74

2.78

- 9 -

Consolidated Statement of Changes in Equity

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020

(Millions of Yen)

Notes

Share capital

Capital reserves

Treasury shares

Other capital

Retained earnings

reserves

Balance at 1 April 2018

6,264

15,899

(10,886)

(6,660)

529,818

Total comprehensive income/(loss) for the year

Profit for the year

122,103

Other comprehensive income/(loss)

26

Total comprehensive income/(loss) for the year

122,103

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(2)

Disposal of treasury shares

20(2)

2,569

(969)

Dividends, 90 yen per share

20(3)

(34,164)

Change in non-controlling interests

20(4)

Share-based payments (stock options)

22

195

Transfer to retained earnings

(297)

Total contributions by and distributions to

owners

2,567

(774)

(34,462)

Total transactions with owners

2,567

(774)

(34,462)

Balance at 31 March 2019

6,264

15,899

(8,319)

(7,434)

617,459

Cumulative effect of accounting change

533

Restated balance at April 1, 2019

6,264

15,899

(8,319)

(7,434)

617,992

Total comprehensive income/(loss) for the year

Profit for the year

114,406

Other comprehensive income/(loss)

26

Total comprehensive income/(loss) for the year

114,406

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(44,261)

(22)

Disposal of treasury shares

20(2)

2,309

(1,032)

Cancellation of treasury shares

20(2)

22,308

(22,308)

Dividends, 90 yen per share

20(3)

(34,064)

Change in non-controlling interests

20(4)

(65)

Share-based payments (stock options)

22

125

Transfer to retained earnings

32

Total contributions by and distributions to

owners

(19,644)

(994)

(56,340)

Total transactions with owners

(19,644)

(994)

(56,340)

Balance at 31 March 2020

6,264

15,899

(27,963)

(8,428)

676,058

- 10 -

(Millions of Yen)

Notes

Balance at 1 April 2018

Total comprehensive income/(loss) for the year

Profit for the year

Other comprehensive income/(loss)

26

Total comprehensive income/(loss) for the year

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

Disposal of treasury shares

20(2)

Dividends, 90 yen per share

20(3)

Change in non-controlling interests

20(4)

Share-based payments (stock options)

22

Transfer to retained earnings

Total contributions by and distributions to

owners

Total transactions with owners

Balance at 31 March 2019

Cumulative effect of accounting change

Restated balance at April 1, 2019

Total comprehensive income/(loss) for the year

Profit for the year

Other comprehensive income/(loss)

26

Total comprehensive income/(loss) for the year

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

Disposal of treasury shares

20(2)

Cancellation of treasury shares

20(2)

Dividends, 90 yen per share

20(3)

Change in non-controlling interests

20(4)

Share-based payments (stock options)

22

Transfer to retained earnings

Total contributions by and distributions to

owners

Total transactions with owners

Balance at 31 March 2020

Financial assets

Exchange differences

Remeasurements of

Share of other

Accumulated other

measured at fair value

the net defined

on translation of

comprehensive

comprehensive

through other

benefit liability

foreign operations

income of associates

income/(loss)

comprehensive income

(asset)

378

(6,652)

(1,969)

(8,242)

697

6,853

(303)

(16)

7,231

697

6,853

(303)

(16)

7,231

(6)

303

297

(6)

303

297

(6)

303

297

1,070

201

(1,985)

(713)

1,070

201

(1,985)

(713)

715

(16,805)

(29)

76

(16,042)

715

(16,805)

(29)

76

(16,042)

(61)

29

(32)

(61)

29

(32)

(61)

29

(32)

1,724

(16,604)

(1,909)

(16,788)

- 11 -

(Millions of Yen)

Equity

Non-controlling

Notes

attributable to owners

Total equity

interests

of the Company

Balance at 1 April 2018

526,193

4,484

530,677

Total comprehensive income/(loss) for the year

Profit for the year

122,103

(31)

122,072

Other comprehensive income/(loss)

26

7,231

(140)

7,091

Total comprehensive income/(loss) for the year

129,334

(171)

129,164

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(2)

(2)

Disposal of treasury shares

20(2)

1,600

1,600

Dividends, 90 yen per share

20(3)

(34,164)

(30)

(34,195)

Change in non-controlling interests

20(4)

269

269

Share-based payments (stock options)

22

195

195

Transfer to retained earnings

Total contributions by and distributions to

owners

(32,372)

238

(32,134)

Total transactions with owners

(32,372)

238

(32,134)

Balance at 31 March 2019

623,155

4,552

627,707

Cumulative effect of accounting change

533

533

Restated balance at April 1, 2019

623,688

4,552

628,240

Total comprehensive income/(loss) for the year

Profit for the year

114,406

181

114,587

Other comprehensive income/(loss)

26

(16,042)

(220)

(16,262)

Total comprehensive income/(loss) for the year

98,364

(39)

98,325

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(44,283)

(44,283)

Disposal of treasury shares

20(2)

1,277

1,277

Cancellation of treasury stock

20(2)

Dividends, 90 yen per share

20(3)

(34,064)

(34,064)

Change in non-controlling interests

20(4)

(65)

(20,289)

(20,354)

Share-based payments (stock options)

22

125

125

Transfer to retained earnings

Total contributions by and distributions to

owners

(77,011)

(20,289)

(97,300)

Total transactions with owners

(77,011)

(20,289)

(97,300)

Balance at 31 March 2020

645,042

(15,777)

629,265

- 12 -

Consolidated Statement of Changes in Equity

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020-Continued

(Thousands of U.S. Dollars (Note 2))

Notes

Share capital

Capital reserves

Treasury shares

Other capital

Retained earnings

reserves

Balance at 31 March 2019

57,560

146,087

(76,441)

(68,311)

5,673,614

Cumulative effect of accounting change

4,895

Restated balance at April 1, 2019

57,560

146,087

(76,441)

(68,311)

5,678,509

Total comprehensive income/(loss) for the year

Profit for the year

1,051,239

Other comprehensive income/(loss)

26

Total comprehensive income/(loss) for the year

1,051,239

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(406,700)

(203)

Disposal of treasury shares

20(2)

21,214

(9,483)

Cancellation of treasury shares

20(2)

204,982

(204,982)

Dividends, 90 yen per share

20(3)

(313,006)

Change in non-controlling interests

20(4)

(597)

Share-based payments (stock options)

22

1,153

Transfer to retained earnings

296

Total contributions by and distributions to

owners

(180,504)

(9,131)

(517,692)

Total transactions with owners

(180,504)

(9,131)

(517,692)

Balance at 31 March 2020

57,560

146,087

(256,945)

(77,442)

6,212,056

(Thousands of U.S. Dollars (Note 2))

Financial assets

Exchange differences

Remeasurements of

Share of other

Accumulated other

Notes

measured at fair value

the net defined

on translation of

comprehensive

comprehensive

through other

benefit liability

foreign operations

income of associates

income/(loss)

comprehensive income

(asset)

1,851

(18,238)

(6,556)

Balance at 31 March 2019

9,832

Cumulative effect of accounting change

Restated balance at April 1, 2019

9,832

1,851

(18,238)

(6,556)

Total comprehensive income/(loss) for the year

Profit for the year

Other comprehensive income/(loss)

26

6,571

(154,415)

(263)

701

(147,406)

Total comprehensive income/(loss) for the year

6,571

(154,415)

(263)

701

(147,406)

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

Disposal of treasury shares

20(2)

Cancellation of treasury shares

20(2)

Dividends, 90 yen per share

20(3)

Change in non-controlling interest

20(4)

Share-based payments (stock options)

22

Transfer to retained earnings

(559)

263

(296)

Total contributions by and distributions to

owners

(559)

263

(296)

Total transactions with owners

(559)

263

(296)

Balance at 31 March 2020

15,844

(152,564)

(17,538)

(154,257)

- 13 -

(Thousands of U.S. Dollars (Note 2))

Equity

Non-controlling

Notes

attributable to owners

Total equity

interests

of the Company

Balance at 31 March 2019

5,725,953

41,824

5,767,777

Cumulative effect of accounting change

4,895

4,895

Restated balance at April 1, 2019

5,730,848

41,824

5,772,672

Total comprehensive income/(loss) for the year

Profit for the year

1,051,239

1,659

1,052,898

Other comprehensive income/(loss)

26

(147,406)

(2,019)

(149,424)

Total comprehensive income/(loss) for the year

903,833

(360)

903,473

Transactions with owners

Contributions by and distributions to owners

Acquisition of treasury shares

20(2)

(406,904)

(406,904)

Disposal of treasury shares

20(2)

11,731

11,731

Cancellation of treasury shares

20(2)

Dividends, 90 yen per share

20(3)

(313,006)

(313,006)

Change in non-controlling interest

20(4)

(597)

(186,432)

(187,030)

Share-based payments (stock options)

22

1,153

1,153

Transfer to retained earnings

Total contributions by and distributions to

owners

(707,623)

(186,432)

(894,055)

Total transactions with owners

(707,623)

(186,432)

(894,055)

Balance at 31 March 2020

5,927,058

(144,968)

5,782,090

- 14 -

Consolidated Statement of Cash Flows

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

Notes

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Cash flows from operating activities

Profit before tax

144,657

147,268

1,353,192

Depreciation and amortisation

26,416

34,374

315,848

Impairment losses

1,099

300

2,760

Finance income

(2,773)

(3,461)

(31,806)

Finance costs

391

791

7,264

Share of (profits)/loss of associates

1,113

1,652

15,182

(Gain)/loss on sales of property, plant and equipment

(492)

(258)

(2,367)

Loss on disposal of property, plant and equipment

609

375

3,444

Gain on business transfer

(3)

Foreign exchange (gain)/loss

342

(567)

(5,209)

Others

7,936

(4,265)

(39,188)

Cash generated from operations (before movements in working

capital)

179,294

176,209

1,619,121

Movements in working capital

Decrease/(increase) in inventories

(6,128)

(2,300)

(21,137)

Decrease/(increase) in trade and other receivables

(3,066)

4,186

38,467

Increase/(decrease) in trade and other payables

4,985

5,152

47,337

Increase/(decrease) in retirement benefit liabilities and provisions

428

433

3,978

Subtotal

175,512

183,680

1,687,766

Interests received

2,435

3,201

29,413

Dividends received

5

14

125

Interest paid

(261)

(511)

(4,700)

Income taxes paid

(31,637)

(23,169)

(212,891)

Income taxes refunded

533

152

1,395

Net cash generated from operating activities

146,588

163,366

1,501,108

Cash flows from investing activities

Withdrawals of time deposits

21,815

2,804

25,763

Payments for time deposits

(18,223)

(2,367)

(21,748)

Proceeds from sales of property, plant and equipment

2,340

472

4,337

Payments for acquisition of property, plant and equipment

(26,672)

(45,177)

(415,116)

Proceeds from sales of investment

10

1,948

17,901

Payments for acquisition of investment

(27,777)

(1,562)

(14,355)

Proceeds from sales of subsidiaries

260

Payments for acquisition of subsidiaries

(19,742)

(969)

(8,903)

Proceeds from business transfer

4

Payments for business transfer

(421)

(542)

(4,976)

Other proceeds

427

226

2,072

Other payments

(2,164)

(2,217)

(20,370)

Net cash used in investing activities

(70,144)

(47,384)

(435,395)

- 15 -

Consolidated Statement of Cash Flows

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020-Continued

Cash flows from financing activities

Notes

Dividends paid to owners of the Company

Dividends paid to non-controlling interests

Net decrease in short-term borrowings

16

Repayments of long-term borrowings

16

Repayments of lease liabilities

16

Payments for redemption of bonds

16

Proceeds from disposal of treasury shares

20(2)

Payments for purchase of treasury shares

20(2)

Proceeds from exercise of stock options

Proceeds from share issuance to non-controlling shareholders

20(4)

Payments for acquisition of non-controlling interests

20(4)

Net cash used in financing activities

Net increase/(decrease) in cash and cash equivalents

Cash and cash equivalents at the beginning of the year

Effects of exchange rate changes on the balance of cash and cash equivalents in foreign currencies

Cash and cash equivalents at the end of the year Note:

Non-cash transactions are stated in Note 28 "Non-cash transactions".

There are no short-term investments within three months as at 31 March 2020.

- 16 -

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

(34,141)

(34,042)

(312,803)

(30)

(775)

(7,121)

(271)

(134)

(1,232)

(7,547)

(69,346)

(14)

0

(2)

(44,283)

(406,904)

1,600

1,277

11,731

67

187

1,715

(149)

(1,372)

(32,792)

(85,468)

(785,332)

43,652

30,514

280,381

245,835

293,397

2,695,923

3,910

(5,930)

(54,484)

293,397

317,982

2,921,820

Notes to the Consolidated Financial Statements

HOYA Corporation and its Subsidiaries

For the year ended 31 March 2020

1. General information

HOYA Corporation (the "Company") is a limited company incorporated in Japan. The addresses of its registered office and principal place of business are disclosed on the Company's website (URL http://www.hoya.com). The principal activities of the Company, its subsidiaries and its associates (the "Group") are described in Note 5 "Operating segment information".

- 17 -

2. Basis of consolidated financial statements

(1) Basis of consolidated financial statements

The accompanying consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRSs").

The accompanying consolidated financial statements are stated in Japanese yen.

The translations of Japanese yen amounts into U.S. dollar amounts are included solely for the convenience of readers outside Japan using the rate of ¥108.83 to $1, the foreign exchange rate at 31 March 2020. Such translations should not be construed as representations that the Japanese yen amounts could be converted into U.S. dollars at that or any other rate. Amounts of less than one million yen and one thousand U.S. dollars have been rounded to the nearest million yen and one thousand U.S. dollars in the presentation of the accompanying consolidated financial statements. As a result, the totals in yen and U.S. dollars do not necessarily agree with the sum of the individual amounts.

The Company and its domestic subsidiaries maintain their books and prepare their financial statements in accordance with accounting principles generally accepted in Japan ("Japanese GAAP") while its foreign subsidiaries maintain their books and prepare their financial statements in conformity with accounting principles generally accepted in the countries of their domicile. Certain adjustments and reclassifications have been incorporated in the accompanying consolidated financial statements to conform to IFRSs. These adjustments were not recorded in their statutory books and ledgers.

(2) Effects of applying new accounting standards

The Group adopted the following IFRS for the year ended 31 March 2020:

IFRSs

Subject of new standards/amendments and transition provisions

IFRS 16

Leases

Amendment to the accounting treatment for lease arrangements

The cumulative effect of initially applying IFRS 16 was recognised at the date of initial application pursuant to a transition method permitted by the standard.

In regard to reassessment, whether a contract is or contains a lease at the date of initial application, the Group chose the practical expedient in paragraph C3 of IFRS 16 and applied IFRS 16 to contracts that had been previously identified as leases applying IAS 17, Leases (hereinafter referred as to "IAS 17"), and IFRIC 4, Determining whether an arrangement contains a lease, and did not apply IFRS16 to contracts that had not. On or after the date of initial application, a lease is identified in accordance with IFRS 16.

A lease liability and a right-of-use asset were recognised at the date of initial application for leases previously classified as operating leases applying IAS 17. A lease liability was measured at the present value of the remaining lease payments, discounted using the lessee's incremental borrowing rate at the date of initial application. This weighted average lessee's incremental borrowing rate is 1.8%. A right-of-use asset was measured at an amount equal to the lease liability, adjusted by the amount of prepaid lease payments for that lease.

The carrying amounts of right-of-use assets and lease liabilities that were previously classified as finance leases applying IAS 17 were measured at the book value immediately before that date of initial application of IFRS16.

The following table shows difference between operating lease commitments disclosed applying IAS 17 at the end of the previous annual reporting period and lease liabilities recognised on the consolidated statement of financial position at the date of initial application.

(millions of yen)

Amount

Operating lease commitments disclosed at 31 March 2019

6,442

Lease liabilities of finance lease (31 March 2019)

862

Non-cancelable operating leases etc.

14,933

Lease liabilities at 1 April 2019

22,237

Right-of-use assets recognised on the consolidated statement of financial position at the date of initial application are ¥25,131 million. The Group used the following practical expedient when applying IFRS 16;

Initial direct costs are excluded from the measurement of the right-of-use assets at the date of initial application.

- 18 -

(3) Standards and interpretations in issue but not yet adopted by the Group

At the date of approval of the consolidated financial statements, the main standards and interpretations that were issued but not yet effective for mandatory adoption are as follows. There are no standards and interpretations that were early adopted by the Group. The implication from the adoption of the revision of IFRS 16 has not yet been fully assessed by the Group. Except for the revision of IFRS 16, the impact of the adoption of these standards and interpretations on the consolidated financial statements of the Group is immaterial.

Mandatory

To be adopted

adoption

by the Group

IFRSs

from

from the year

the year

ending

beginning)

IFRS 10

Consolidated Financial

(Revised)

Statements

Not determined

Not determined

IAS 28

Investments in Associates

(Revised)

and Joint Ventures

IFRS 16

Leases

1 June 2020

31 March 2021

(Revised)

Subject of new standards/amendments

Amendments to the accounting treatment for sale or contribution of assets between an investor and its associate or joint venture

Amendments to provide lessees with a practical expedient that relieves a lessee from assessing whether a rent concession is a lease modification in a certain condition

- 19 -

3. Significant accounting policies

(1) Basis of preparation

The consolidated financial statements have been prepared on the historical cost basis except for certain non-current assets and financial instruments measured at revalued amounts or fair value. The principal accounting policies are set out below.

(2) Basis of consolidation

  • Subsidiaries

The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Company as at 31 March of each year. An investor controls an investee when it is exposed or has rights to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. The Group reassesses whether it controls an investee if facts and circumstances indicate that there are changes to elements of control.

The operating results of the subsidiaries are included in the consolidated statement of comprehensive income from the effective date the Group obtained control of the subsidiaries to the effective date the Group lost control, as appropriate. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by other members of the Group. All intragroup transactions, balances, income and expenses are eliminated in full in preparing the consolidated financial statements.

Changes in an interest of a subsidiary without losing control are accounted for as equity transactions. The carrying amounts of the controlling and non-controlling interests are adjusted to reflect the changes in their respective percentage of interests in the subsidiary. If there is a difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received, the difference is recognised directly in equity and attributed to the owners of the parent.

If loss in control of a subsidiary occurs, the Group recognises in profit or loss any resulting difference of the following:

  1. sum of the fair value of any consideration received and any investment retained in the former subsidiary at its fair value; and
  2. previous carrying amounts of the assets (including goodwill), and liabilities of the subsidiary and any non-controlling interests.

Non-controlling interests in subsidiaries are identified separately from the Group's equity therein. Non-controlling interests consist of those interests at the date of the original business combination and the non-controlling share of changes in equity since the date of the combination. Total comprehensive income is attributed to the owners of the Company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.

  • Investments in associates

An associate is an entity over which the Group has significant influence and that is neither a subsidiary nor an interest in a joint venture. The results of and the investments in associates are incorporated in the consolidated financial statements using the equity method of accounting, except when the investment is classified as an asset held for sale, in which case it is accounted for in accordance with IFRS 5 "Non-current Assets Held for Sale and Discontinued Operations".

Under the equity method, investments in associates are carried in the consolidated statement of financial position at cost and then adjusted for post-acquisition changes in the Group's share of the net assets of the associates, less any impairment in the value of the investments.

Losses of an associate in excess of the Group's interest in that associate (which includes any long-term interests that, in substance, form part of the Group's net investment in the associate) are recognised only to the extent that the Group has incurred legal or constructive obligations or made payments on behalf of the associate and the excess of those losses is no longer recognised.

- 20 -

Any excess of the cost of acquisition over the Group's share of the net fair value of the identifiable assets, liabilities and contingent liabilities of the associate recognised at the date of acquisition is tested for impairment. Any excess of the Group's share of the net fair value of the identifiable assets, liabilities and contingent liabilities over the cost of acquisition is recognised immediately in profit or loss. When a group entity transacts with an associate of the Group, profits and losses are eliminated to the extent of the Group's interest in the relevant associate.

  • Joint arrangements

The Group classifies joint arrangements as either joint operations (having rights to assets and obligations for liabilities accounted for accordingly) or joint ventures (having rights to net assets and equity accounted). The classification depends upon the rights and obligations of the parties to the arrangement.

Joint operators shall account for the assets, liabilities, revenues and expenses relating to their interests in joint operations. Joint ventures shall apply the equity method. The Group has neither joint operations nor joint ventures.

(3) Business combinations

Acquisitions of businesses are accounted for using the acquisition method. Acquisition-related costs are generally recognised in profit or loss as incurred. The acquiree's identifiable assets acquired and liabilities assumed are recognised at their fair values at the acquisition date, except for the following:

  • a deferred tax asset or liability arising from the assets acquired and liabilities assumed, and a liability (or asset, if any) related to the acquiree's employee benefit arrangements;
  • a liability or an equity instrument related to the replacement of an acquiree's share-based payment awards with share-based payment awards of the acquirer; and
  • an asset or disposal group that is classified as held for sale at the acquisition date in accordance with IFRS 5 "Non-current Assets Held for Sale and Discontinued Operations".

When the consideration transferred by the Group in a business combination includes assets or liabilities resulting from a contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Changes in the fair value of the contingent consideration that qualify as measurement period adjustments are adjusted retrospectively, with corresponding adjustments against goodwill. Measurement period adjustments are adjustments that arise from additional information obtained during the "measurement period" (which cannot exceed one year from the acquisition date) about facts and circumstances that existed at the acquisition date.

Changes in the fair value of the contingent consideration resulting from events after the acquisition date are accounted for as follows:

  1. Contingent consideration classified as equity is not remeasured and any subsequent settlement is accounted for in equity; or
  2. Contingent consideration classified as an asset or a liability is accounted for in accordance with IAS 37, "Provisions, Contingent Liabilities and Contingent Assets", and IFRS 9, "Financial Instruments", or other IFRSs as appropriate.

Goodwill is measured on the basis of the excess of the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree, and the fair value of the acquirer's previously held equity interest in the acquiree over the fair value of identifiable assets acquired, net of liabilities assumed at acquisition date. Negative goodwill is recognised immediately in profit or loss as a bargain purchase gain.

- 21 -

Non-controlling interests in subsidiaries are reported in equity separately from the equity attributable to owners of the Company. Non- controlling interests are initially measured either at fair value or at the non-controlling interests' proportionate share of the recognised amounts of the acquiree's identifiable net assets on a transaction-by-transaction basis.

When a business combination is achieved in stages, the Group's previously held equity interest in the acquiree is remeasured to the fair value at the acquisition date (i.e., the date when the Group obtains control) and the resulting gain or loss, if any, is recognised in profit or loss. Amounts arising from interests in the acquiree prior to the acquisition date that were previously recognised in other comprehensive income are reclassified to profit or loss where such treatment would be appropriate if that interest were disposed of.

Goodwill arising from business combinations before the IFRSs transition date is measured at carrying amount in accordance with the previous GAAP (i.e., Japanese GAAP) after performing an impairment test.

(4) Foreign currencies

  • Foreign currency transactions

The individual financial statements of each group entity are presented in the currency of the primary economic environment in which the entity operates (i.e., its functional currency). For the purpose of the consolidated financial statements, the financial results, financial position and cash flows of each Group entity are presented in Japanese yen, which is the functional currency of the Company and the presentation currency for the consolidated financial statements.

In preparing the financial statements of the individual entities, transactions in currencies other than the entity's functional currency (foreign currencies) are translated at the rates of exchange prevailing at the dates of the transactions.

At the end of each reporting period, monetary items denominated in foreign currencies are translated at the rates prevailing at that date. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Exchange differences are recognised in profit or loss during the period.

  • Financial statements of foreign operations

The assets and liabilities of foreign operations are translated into Japanese yen at the foreign exchange rates prevailing at the end of the reporting period. The revenues and expenses of foreign operations are translated into Japanese yen at the average rates of exchange for the year. Where there are material fluctuations in exchange rates, the exchange rate at the transaction date is used. Foreign exchange differences arising from translation are initially recognised as exchange differences on translation of foreign operations in other comprehensive income and accumulated in 'accumulated other comprehensive income', which are reclassified from equity to profit or loss on disposal of the net investment and included in 'other expenses' in the consolidated statement of comprehensive income.

- 22 -

(5) Property, plant and equipment

The Group applies the cost model for measuring property, plant and equipment.

Property, plant and equipment are stated at cost, net of accumulated depreciation and impairment losses. Properties in the course of construction for production, supply or administrative purposes, or for purposes not yet determined, are carried at cost, less any recognised impairment losses. Cost includes the expenses directly attributable to the assets; the initial estimated costs relating to scrap, removal and retirement; and, for qualifying assets, the borrowing cost for long-term projects. Depreciation of these assets commences when the assets are available for their intended use.

When significant components of property, plant and equipment are required to be replaced periodically, the Group recognises such components as individual assets to be depreciated with specific useful lives. All other repair and maintenance costs are recognised in profit or loss as incurred.

Property, plant and equipment other than land and construction in progress are depreciated mainly on a straight-line basis over the following estimated useful lives. The estimated useful lives, residual values and depreciation method are reviewed at each year-end, with the effect of any changes in estimate being accounted for on a prospective basis.

Buildings and structures: 3-50 years

Machinery and carriers: 3-10 years

Tools, equipment and fixtures: 2-10 years

(6) Leases

As a lessee, the Group recognises a right-of-use asset and a lease liability at the commencement date. The lease liability is measured at the present value of the lease payments that are not paid at the commencement date. The right-of-use asset is measured at cost comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, any initial direct costs incurred and an estimate of costs, such as the cost to dismantle and remove the underlying asset to the original condition required by the terms and conditions of lease contracts.

After the commencement date, the right-of-use asset is depreciated on a straight-line basis over the useful life or lease term, whichever is shorter.

The lease payments comprise of interest expense recognised as finance costs in the consolidated statement of comprehensive income and repayments of the lease liability that are calculated by the interest method. The Group does not recognise right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and for leases of low-value assets. The Group recognises the lease payments associated with these leases as expense on straight-line basis over the lease term or other systematic basis.

As a lessor, the Group classifies each of its leases as either an operating lease or a finance lease. A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership of an underlying asset. A lease is classified as an operating lease if it does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.

At the commencement date, the asset held under a finance lease is recognised on the consolidated statement of financial position and presented as a receivable at an amount equal to the net investment in the lease.

The assets held under an operating lease are on the consolidated statement of financial position and the lease payments received are recognised as income on a straight-line basis over the lease term in the consolidated statements of comprehensive income.

- 23 -

(7) Intangible assets

The Group uses the cost model for measuring intangible assets. Intangible assets are carried at cost less accumulated amortisation and impairment losses.

  • Intangible assets acquired separately and/or acquired in a business combination

Intangible assets acquired separately are carried at cost at initial recognition. Intangible assets acquired in a business combination are recognised separately from goodwill at their fair value at the acquisition date, when they are satisfied with the definition of intangible assets, identifiable, and their fair value is reasonably measured.

  • Internally-generatedintangible assets-research and development ("R&D") costs Expenditures on research activities are recognised as expense in the period in which they are incurred.

An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognised if, and only if, all of the following have been demonstrated:

  1. the technical feasibility of completing the intangible asset so that it will be available for use or sale;
  2. the intention to complete the intangible asset and use or sell it;
  3. the ability to use or sell the intangible asset;
  4. how the intangible asset will generate probable future economic benefits;
  5. the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
  6. the ability to measure reliably the expenditure attributable to the intangible asset during its development.

The amount initially recognised for internally-generated intangible assets is the sum of the expenses incurred from the date when the intangible assets first meet all of the recognition criteria listed above. The assets are amortised over the estimated period in which the development costs are expected to be recovered. If no future economic benefit is expected before the end of the life of assets, the residual carrying amount is expensed.

Subsequent to initial recognition, internally-generated intangible assets are reported at cost less accumulated amortisation and impairment losses. Where no internally-generated intangible asset can be recognised, development costs are recognised as an expense in the period in which they are incurred.

  • Amortisation of intangible assets

Amortisation is recognised on a straight-line basis over the estimated useful lives below. The Group does not have any intangible assets with indefinite useful lives.

Technology: 5-20 years

Customer related assets: 5-16 years

Software: 3-5 years

  • Derecognition of intangible assets

An intangible asset is derecognised on disposal or when no future economic benefits are expected from use or disposal. Gains or losses arising from derecognition of an intangible asset are recognised in profit or loss when the asset is derecognised.

- 24 -

(8) Goodwill

Goodwill arising from the acquisition of a business is recognised as an asset at the date that control is acquired (i.e., the acquisition date). Goodwill is measured as the excess of the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree, and the fair value of the acquirer's previously held equity interest in the acquiree (if any) over the acquisition-date amounts of the net fair value of the identifiable assets acquired and the liabilities assumed. Goodwill is not amortised but is reviewed for impairment at least annually. Goodwill is recorded at cost less accumulated impairment losses on the consolidated statement of financial position.

For the purposes of impairment testing, goodwill is allocated to each of the Group's cash-generating units (or groups of cash- generating units) that is expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment losses are allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit on a pro-rata basis of the carrying amount of each asset in the unit. Impairment losses recognised for goodwill are not reversed in subsequent periods. Upon disposal of a cash- generating unit, goodwill attributed to the unit is included in the determination of the profit or loss upon disposal.

The Group's accounting policy for goodwill arising on the acquisition of an associate is described at "(2) Basis of consolidation - Investments in associates" above.

(9) Impairment of property, plant and equipment and intangible assets other than goodwill

At the end of each reporting period, the Group reviews the carrying amounts of its property, plant and equipment and intangible assets to determine whether there are any indications that those assets have suffered impairment losses. If any such indication exists, the recoverable amount of the cash-generating unit to which the asset belongs is estimated in order to determine the extent of the impairment losses (if any).

Where a reasonable and consistent basis of allocation can be identified, corporate assets (i.e., assets other than goodwill that contribute to the future cash flows of both the cash-generating unit under review and other cash-generating units) are also allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount.

Where impairment losses subsequently reverse, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, such that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment losses been recognised for the asset (or cash-generating unit) in prior years. A reversal of impairment losses is recognised immediately in profit or loss.

- 25 -

(10) Derivative financial instruments

Derivatives are initially recognised at fair value at the date the derivative contract is entered into and are subsequently remeasured at their fair value at the end of each reporting period.

(11) Financial assets other than derivative financial instruments

  • Initial recognition and measurement

Financial assets are classified as "financial assets measured at amortised cost," "financial assets measured at fair value through other comprehensive income" ("FVTOCI") or "financial assets measured at fair value through profit and loss" ("FVTPL"). The classification is determined at the time of initial recognition

The Group recognises a financial asset on the trade date when it becomes party to the contract of the financial asset.

All financial assets are measured at the fair value plus transaction costs, except for FVTPL.

  • Financial assets measured at amortised cost

Such financial assets are held within a business model whose objective is to hold financial assets to collect contractual cash flows, and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

After initial recognition, "Financial assets measured at amortised cost" are measured at amortised cost by using the effective interest method, less the cumulative amount of impairment losses.

  • Financial assets classified as FVTOCI

Such financial assets are measured at fair value through other comprehensive income if both of the following conditions are met:

  1. the financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets
  2. the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. The change in fair value is recognised in other comprehensive income.

The fair value of a particular asset in an equity instrument for which the Group makes an irrevocable election at initial recognition to present in other comprehensive income subsequent changes in its fair value is recognised in other comprehensive income.

  • Financial assets classified as FVTPL

Any other securities not included in the classifications above are classified into financial assets measured at fair value through profit and loss. The change in fair value is recognised in profit or loss.

  • Impairment of financial assets

The Group recognises a loss allowance for expected credit losses on "financial assets measured at amortised cost".

The Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition. If the credit risk on a financial instrument has not increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to 12-month expected credit losses. If the credit risk on a financial instrument has increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to the lifetime expected credit losses. For trade receivables, the Group always measures the loss allowance at an amount equal to the lifetime expected credit losses. The Group assesses the expected credit losses by using the change in the risk of a default or ageing of trade receivables, etc. It is recognised in profit or loss.

  • Derecognition of financial assets

The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another entity. If the Group retains substantially all the risks and rewards of ownership of a transferred financial asset, the Group continues to recognise the financial asset and a collateralised borrowing for the proceeds received.

- 26 -

(12) Inventories

Inventories are measured at the lower of cost and net realisable value. Net realisable value represents the estimated selling price for the inventories in the ordinary course of business, less all estimated costs of completion and costs necessary to make the sale. Costs, including purchase costs, process costs, storage costs and all other costs incurred in bringing the inventories to their present location and condition, are assigned to inventories mainly by the weighted-average method. The production costs include an appropriate portion of fixed and variable overhead expenses.

(13) Cash and cash equivalents

Cash and cash equivalents are composed of cash on hand and bank deposits including short-term investments. The short-term investments with original maturities of three months or less are deemed as cash equivalents since they are readily convertible to cash without restriction and with low risk of fluctuation of values.

(14) Assets held for sale

Non-current assets and disposal groups are classified as held for sale if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset (or disposal group) is available for immediate sale in its present condition. Management must be committed to the sale, which should be expected to qualify for recognition as a completed sale within one year from the date of classification.

When the Group is committed to a sale plan involving loss of control of a subsidiary, all of the assets and liabilities of that subsidiary are classified as held for sale when the criteria described above are met, regardless of whether the Group will retain a non-controlling interest in its former subsidiary after the sale.

Assets classified as held for sale are measured at the lower of their previous carrying amount and fair value less costs to sell. Property, plant and equipment and intangible assets classified as held for sale are not depreciated or amortised after their classification.

- 27 -

(15) Treasury shares

The Group's own equity instruments, which are reacquired (i.e., treasury shares), are recognised at cost and deducted from equity. No gain or loss is recognised on the purchase, disposal or cancellation of the Group's own equity instruments. Any difference between the carrying amount and the consideration given is recognised in other capital reserves.

(16) Share-based payments

Equity-settledshare-based payments (i.e., stock options), which are incentive plans to the Group's directors, officers and certain employees, are measured at the fair value of the equity instruments at the grant date. Details regarding the determination of the fair value of equity-settledshare-based transactions are set out in Note 22 "Share-based payments".

The fair value determined at the grant date of the equity-settledshare-based payments is expensed on a straight-line basis over the vesting period while the corresponding amount to other capital reserves is recognised, based on the Group's estimate of equity instruments that will eventually vest. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognised in profit or loss such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to other capital reserves.

(17) Dividend distributions

Dividend distributions to the Company's shareholders are recognised as liabilities in the consolidated financial statements in the period in which the dividends are approved by the Company's board of directors.

- 28 -

(18) Financial liabilities issued by the Group excluding derivative instruments

  • Financial liabilities

Financial liabilities are classified as either financial liabilities classified as FVTPL or financial liabilities measured at amortised cost. This classification is determined at initial recognition.

  • Financial liabilities classified as FVTPL

Financial liabilities classified as FVTPL are either held for trading or designated as FVTPL at initial recognition. They are measured at fair value, and the subsequent changes are recognised in profit and loss.

  • Financial liabilities measured at amortised cost

Financial liabilities measured at amortised cost are measured at fair value minus transaction costs at initial recgnition. After the initial recognition, they are measured at amortised cost by using the effective interest method. The gain or loss on cease of amortisation or derecognition is recognised in profit and loss as part of financial costs.

  • Derecognition of financial liabilities

The Group derecognises financial liabilities when, and only when, the Group's obligations are discharged, cancelled or expired.

  • Financial guarantee contracts

Financial guarantee contracts are initially measured at their fair values and subsequently measured at the higher of:

  • the amount of loss allowance for expected credit losses, as determined in accordance with IFRS 9, "Financial Instruments"; and
  • the amount initially recognised less cumulative amortisation recognised in accordance with IFRS 15, "Revenue from Contracts with Customers".

- 29 -

(19) Retirement benefit costs

For defined benefit plans, the cost of providing retirement benefits is determined using the projected unit credit method, with actuarial valuations being carried out at the end of each reporting period.

Remeasurement, comprising actuarial gains and losses, the effect of the changes to the asset ceiling (if applicable) and the return on plan assets (other than interest), is reflected immediately in the consolidated statement of financial position with a charge or credit recognised in other comprehensive income in the period in which they occur. Remeasurement recognised in other comprehensive income is reflected immediately in retained earnings and will not be reclassified to profit or loss.

Past service cost is recognised in profit or loss in the period of a plan amendment.

Net interest is calculated by applying the discount rate at the beginning of the period to the net defined benefit liability or asset.

Defined benefit costs are categorised as follows:

  • Service cost (including current service cost, past service cost, as well as gains or losses on curtailments and settlements);
  • Net interest expense or income; or
  • Remeasurement.

The Group presents the first two components of defined benefit cost in profit or loss as "Employee benefits expense" or "Finance cost".

The retirement benefit liabilities recognised in the consolidated statement of financial position represent the actual deficit or surplus in the Group's defined benefit plans. Any surplus resulting from this calculation is limited to the present value of any economic benefits available in the form of refunds from the plans or reductions in future contributions to the plans.

Payments to defined contribution retirement benefit plans are recognised as an expense when employees have rendered service to the Group.

- 30 -

(20) Provisions and contingent liabilities assumed in a business combination

Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that the Group will be required to settle the obligation by outflow of resources embodying economic benefits, and a reliable estimate can be made of the amount of the obligation. The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the end of the reporting period (i.e., future cash outflow), taking into account the risks and uncertainties surrounding the obligation.

Where time value of money is material, a provision is measured at the present value to which estimated future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the obligation. Interest cost associated with the passage of time is recognised as finance cost.

The types of provisions are as follows:

  • Asset retirement obligation

The Group recognises provisions for an asset retirement obligation for estimated costs arising from a contractual obligation to a landlord to dismantle and remove leasehold improvements from a leased office at the end of the lease contract, and estimated costs to decontaminate certain fixed assets. An asset retirement obligation is provided based on past experience of actual cost and each asset is considered individually. The discount rate depends on the useful life of the corresponding assets and the country in which such assets are located. Future expected timing of outflow of economic benefits is mainly more than one year from each reporting period.

  • Warranties provision

Warranties provision is estimated and recognised based on past experience of the occurrence of defective goods and the expected after service costs in the warranty period. Expected outflow of economic benefits in the future is within one year from each reporting period.

  • Contingent liabilities assumed in a business combination

Contingent liabilities resulting from a business combination are initially measured at fair value at the date of acquisition. Subsequent to initial recognition, such contingent liabilities are remeasured considering expected future payments, possible occurrence and timing of payments at each reporting period.

- 31 -

(21) Revenue

The Group recognises revenue based on the five-step approach below:

Step 1: Identify the contracts with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognise revenue when the entity satisfies a performance obligation

The Group sells health care related products, medical related products, electronics related products and imaging related products, etc. Revenue is recognised at the fair value of the consideration received or receivable less discount, rebate and consumption taxes on the shipping or delivery date, or upon the completion of inspection by customers when the control of products is transferred to the customer and the performance obligation is satisfied by the Group.

(22) Government grants

Government grants are measured and recognised at fair value when there is reasonable assurance that the Group will comply with the conditions attached to them and that the grants will be received.

Government grants associated with an expense are recognised as revenue in the same accounting period when the expense is incurred. Government grants for purchase of assets are recognised as deferred revenue in the consolidated statement of financial position and transferred to profit or loss on a systematic basis over the useful lives of the related assets.

- 32 -

(23) Income taxes

Income tax expense represents the sum of the current tax and deferred tax. Current and deferred taxes are recognised in profit or loss, except when they relate to items that are recognised directly in other comprehensive income or equity, or where they arise from the initial accounting for a business combination.

The current tax is calculated based on estimated refund or payment from/to taxation authorities. The Group's current tax liability is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period based on the taxable profit or loss for the Group's operating activity in each country.

Deferred tax is provided using the asset and liability method on temporary differences, tax loss carryforwards and tax credits at the reporting date.

Deferred tax assets or liabilities are not recognised for:

  • Temporary differences arising from the initial recognition of goodwill
  • Temporary differences arising from the initial recognition of assets and liabilities in transactions that do not affect either accounting profit or taxable profit (excluding business combinations)
  • Taxable temporary differences associated with investments in subsidiaries and associates where the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.

Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets arising from deductible temporary differences are only recognised to the extent that it is probable that there will be sufficient taxable profits against which the benefits of the temporary differences can be utilised and they are expected to reverse in the foreseeable future.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Unrecognised deferred tax assets are reassessed at each reporting date and are recognised to the extent that it has become probable that future taxable profits will allow the deferred tax assets to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off the current tax assets against the current tax liabilities and when they relate to income taxes levied by the same tax authority.

In the case of a business combination, the tax effect is included in the accounting for the business combination when measuring the amount of goodwill or determining negative goodwill.

(24) Earnings per share

Basic earnings per share amounts are calculated by dividing net profit for the year attributable to ordinary equity holders of the parent by the weighted-average number of ordinary shares outstanding during the year. Diluted earnings per share amounts are calculated by adjusting profit or loss attributable to ordinary equity holders of the parent and the weighted-average number of ordinary shares outstanding, for the effect of all potential dilutive ordinary shares.

(25) Reclassification

Certain reclassifications have been made to prior year amounts to conform to the current year presentation.

- 33 -

4. Critical accounting judgements and key sources of estimation uncertainty

(1) Application of estimates and assumptions

Preparation of consolidated financial statements requires management to make estimates and assumptions in order to determine the reported amounts of certain assets, liabilities, income and expense items. Regarding the impact of novel coronavirus, the result of Life Care segment is estimated based on the assumption that it will recover after a while later in the end. The result of Information Technology segment is estimated based on the assumption that the impact is short-term.

The following are items that require estimates and assumptions and are considered significant:

  • Determination of net realisable value of obsolete inventory (Note 14 "Inventories")
  • Expected cash flow from overdue trade and other receivables (Note 21 "Financial instruments")
  • Useful lives of property, plant and equipment, right-of-use assets and intangible assets (Note 3 "Significant accounting policies", Note 3 (5) "Property, plant and equipment", Note 3 (6) "Leases" and Note 3 (7) "Intangible assets")
  • Lease period of right-of-use assets (Note 3 "Significant accounting policies", (6) "Leases")
  • Assumptions used to estimate future cash flows of cash-generating units to assess the recoverability of property, plant and equipment and intangible assets, including goodwill (Note 9 "Impairment losses")
  • Financial asset measured at fair value (Note 21 "Financial instruments")
  • Recoverability of deferred tax assets (Note 11 "Deferred taxes and income taxes")
  • Assumptions used for treatment of retained earnings of overseas subsidiaries and associates for tax purposes (Note 11 "Deferred taxes and income taxes")
  • Assumptions used to calculate retirement benefit obligations (Note 17 "Retirement benefit plans")
  • Asset retirement obligations arising from legal obligations and constructive obligations (Note 18 "Provisions")
  • Fair value of stock options (Note 22 "Share-based payments")

The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from those estimates. The estimates and underlying assumptions are reviewed on an ongoing basis.

Revisions of accounting estimates will affect current and/or future periods.

(2) Key sources of risk and estimation uncertainty

The Group's financial position, financial performance and cash flows are exposed to the following risks and uncertainties:

  • Tough competition and excess-supply of inventory in markets in which the Group operates
  • Development of new products and timing of development
  • Changes in the political, economic and regulatory environment, shortage of labour, labour strikes, natural disasters, and impacts of unexpected international affairs in the countries in which the Group is located and operates
  • The effect of deferred taxes and income taxes on transactions between locations in different tax jurisdictions with

different tax rates, or transactions between taxable and tax-exempt businesses (including discrepancies in opinion between the Company and the tax authority)

  • Fluctuations of currency exchange rates
  • The trend of environmental and governmental regulations

Global economic stagnation and the occurrence of natural disasters may have a significant impact on future profitability of the Group. Future profitability of the Group may affect the estimates for the following:

  • Impairment of property, plant and equipment and intangible assets including goodwill (Note 9 "Impairment losses")
  • Recoverability of deferred tax assets (Note 11 "Deferred taxes and income taxes")

- 34 -

5. Operating segment information

(1) Overview of major products and services of reportable segments

Reportable segments are components of the Group for which separate financial information is obtained and examined on a regular basis by the board of directors and the chief operating decision maker to determine the allocation of management resources and evaluate the business performance.

In accordance with its management philosophy, the Group has categorised "life and culture" and "information technology" as its business domains. To achieve sustainable growth in corporate value in these business domains, the Group has been making decisions on the allocation of management resources and monitoring the operating results.

As a result, the Group consists of three reportable business segments: the Life Care business, the Information Technology business and Other business, which are consistent with the above business domains.

In the Life Care business, the Group produces and sells health care related products that are used in the health care and medical sectors and medical related products, including medical equipment and medical materials that are used in medical treatments. In operating this business, it is typically a requirement to obtain approvals and permissions in accordance with the Pharmaceutical Affairs Act of Japan and other regulations, and sophisticated technologies and highly reliable quality control systems represent critical elements for operating this business.

In the Information Technology business, the Group has developed an extensive range of products following the digitalisation of information and the emergence of the Internet. The Group produces and sells a broad array of I/O (Input/Output Device) related products in the information and communication sector, including electronics related products that are essential for the modern digital information and communication technologies, and imaging related products that are necessary to import pictures and video images as digital information based on optical technologies.

Other business mainly includes the business that provides information system services and new businesses.

The main products and services for each reportable segment described above are as follows:

Reportable Segment

Major Products and Services

Life Care

Health Care related products

Eyeglass lenses and Contact lenses

Medical related products

Endoscopes, Medical accessories, Intraocular lenses, Artificial bone,

Metallic implants for orthopedics

Information Technology

Electronics related products

Photomasks and Maskblanks for semiconductors,

Masks and Devices for liquid-crystal displays (LCDs)

Glass disks for hard disk drives (HDDs)

Imaging related products

Optical lenses, Optical glasses, Laser equipment

Other

Design of information systems and other services

- 35 -

(2) Segment revenues and results

The following is an analysis of the Group's revenue and results from continuing operations by reportable segment.

The accounting policies of the reportable segments are the same as the Group's accounting policies described in Note 3 "Significant accounting policies".

Millions of Yen

For the year ended 31 March

Life Care

Information

Other

Total

Adjustments

Consolidated

2019

Technology

Revenue from external

customers

373,388

187,546

4,875

565,810

565,810

Inter-segment sales

3

96

1,511

1,610

(1,610)

Total

373,391

187,643

6,386

567,420

(1,610)

565,810

Interest income

665

708

3

1,376

1,387

2,763

Interest expense

(1,475)

(330)

(0)

(1,806)

1,415

(391)

Depreciation and amortisation

(17,349)

(8,478)

(411)

(26,238)

(178)

(26,416)

Share of profit (loss) of

associates

39

20

59

(1,172)

(1,113)

Impairment losses

(690)

(281)

(971)

(128)

(1,099)

Others

(285,291)

(98,685)

(5,240)

(389,216)

(5,682)

(394,897)

Segment profit before tax

69,290

80,596

737

150,623

(5,967)

144,657

Other disclosure

Capital expenditure

19,108

9,933

52

29,092

112

29,204

Note:

Adjustments to segment profit before tax of (5,967) million yen for the year ended 31 March 2019 consist of elimination of inter- segment transactions of (1) million yen, and profit or loss of the Company's headquarter, the R&D department and overseas holding companies (after elimination of dividend income from Group companies) of (5,966) million yen .

Millions of Yen

For the year ended 31 March

Life Care

Information

Other

Total

Adjustments

Consolidated

2020

Technology

Revenue from external

customers

375,049

196,731

4,766

576,546

576,546

Inter-segment sales

3

26

1,148

1,177

(1,177)

Total

375,051

196,757

5,915

577,723

(1,177)

576,546

Interest income

529

944

11

1,484

1,967

3,452

Interest expense

(1,343)

(422)

(1)

(1,766)

1,154

(612)

Depreciation and amortisation

(23,845)

(9,548)

(494)

(33,888)

(486)

(34,374)

Share of profit (loss) of

associates

69

17

86

(1,739)

(1,652)

Impairment losses

(1)

(300)

(300)

(300)

Others

(288,230)

(99,314)

(5,399)

(392,942)

(2,849)

(395,791)

Segment profit before tax

62,230

88,135

32

150,397

(3,129)

147,268

Other disclosure

Capital expenditure

24,944

28,939

70

53,952

196

54,148

- 36 -

Thousands of U.S. Dollars (Note 2)

For the year ended 31 March

Life Care

Information

Other

Total

Adjustments

Consolidated

2020

Technology

Revenue from external

customers

3,446,191

1,807,690

43,797

5,297,677

5,297,677

Inter-segment sales

23

239

10,552

10,815

(10,815)

Total

3,446,214

1,807,929

54,349

5,308,492

(10,815)

5,297,677

Interest income

4,859

8,678

102

13,639

18,076

31,715

Interest expense

(12,344)

(3,874)

(12)

(16,231)

10,605

(5,625)

Depreciation and amortisation

(219,107)

(87,738)

(4,535)

(311,380)

(4,468)

(315,848)

Share of profit (loss) of

associates

638

155

793

(15,975)

(15,182)

Impairment losses

(6)

(2,754)

(2,760)

(2,760)

Others

(2,648,440)

(912,559)

(49,606)

(3,610,605)

(26,179)

(3,636,784)

Segment profit before tax

571,814

809,837

297

1,381,948

(28,755)

1,353,192

Other disclosure

Capital expenditure

229,197

265,906

645

495,748

1,801

497,549

Note:

Adjustments to segment profit before tax of (3,129) million yen ((28,755) thousand U.S. dollars) for the year ended 31 March 2020 consist of elimination of inter-segment transactions of 1 million yen (9 thousand U.S. dollars), and profit or loss of the Company's headquarters, the R&D department and overseas holding companies (after elimination of dividend income from Group companies) of (3,130) million yen ((28,765) thousand U.S. dollars).

- 37 -

(3) Revenue from major products and services

The following is an analysis of the Group's revenue from continuing operations from its major products and services for the years ended 31 March 2019 and 2020:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Life Care

Health Care related products

281,613

277,798

2,552,586

Medical related products

91,775

97,251

893,605

Life Care total

373,388

375,049

3,446,191

Information Technology

Electronics related products

146,623

162,655

1,494,580

Imaging related products

40,924

34,076

313,109

Information Technology total

187,546

196,731

1,807,690

Other

4,875

4,766

43,797

Corporate (R&D)

Total revenue from external

565,810

576,546

5,297,677

customers

  1. Information about geographical areas Revenue from external customers

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Japan

163,821

163,045

1,498,158

U.S.A.

85,473

83,816

770,157

Singapore

42,473

54,656

502,214

China

46,439

44,835

411,975

South Korea

27,099

31,702

291,299

Others

200,505

198,492

1,823,874

Total

565,810

576,546

5,297,677

Note:

Geographical areas are based on the location of the customers.

Non-current assets in China and South Korea are insignificant; therefore, the amount is included in Others.

- 38 -

Non-current assets

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

U.S.A.

67,020

66,763

613,458

Japan

26,816

36,634

336,612

Thailand

19,510

20,213

185,730

Vietnam

10,272

17,434

160,195

Singapore

6,844

17,210

158,134

Others

68,465

75,971

698,072

Total

198,926

234,224

2,152,201

Note:

  1. Geographical areas are based on the physical location of non-current assets.
  2. Financial instruments, deferred tax assets, and pension plan assets are not included.

Revenue from external customers in Thailand and Vietnam is insignificant; therefore, the amount is included in Others.

(5) Information about major customers

The Group has no revenue from transactions with a single external customer that amounts to 10% or more of revenue of the Group.

- 39 -

6. Property, plant and equipment

The following are the cost, accumulated depreciation, impairment losses and carrying amount of property, plant and equipment:

Millions of Yen

Cost

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 1 April 2018

101,448

283,897

63,872

9,576

5,955

464,749

Additions

1,489

2,639

22,694

27,759

938

Acquisitions through business

combinations

566

439

406

48

382

1,841

Disposals (i)

(3,037)

(11,147)

(4,238)

(479)

(118)

(19,019)

Transfer from construction in

progress

1,490

8,649

1,141

0

(11,280)

Effect of foreign currency

exchange differences

104

1,457

(1,644)

49

87

54

Others

(92)

(2,097)

2,289

39

(1,372)

(1,232)

Balance at 31 March 2019

101,418

282,687

64,465

9,233

16,348

474,150

Cumulative effect of

accounting change

(780)

(15)

(635)

25,903

24,473

Restated balance at 1 April

100,637

282,672

63,829

9,233

16,348

25,903

498,624

2019

Additions

543

1,797

2,495

42,026

5,925

52,786

Acquisitions through business

combinations

33

16

116

165

Disposals (i)

(1,751)

(8,004)

(2,297)

(38)

(301)

(1,019)

(13,410)

Transfer from construction in

progress

3,198

16,526

1,949

(21,673)

Effect of foreign currency

exchange differences

(3,112)

(8,844)

(2,415)

(136)

(572)

(1,039)

(16,119)

Others

(597)

79

1,009

(199)

986

200

1,478

Balance at 31 March 2020

98,951

284,225

64,586

8,860

36,815

30,087

523,524

- 40 -

Millions of Yen

Accumulated depreciation and

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

impairment losses

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 1 April 2018

(66,738)

(252,152)

(39,339)

(978)

(49)

(359,256)

Depreciation expense

(12,700)

(4,303)

(20,858)

(3,856)

Impairment losses (ii)

(51)

(370)

(360)

(128)

(113)

(1,023)

Disposals (i)

2,824

9,910

4,058

3

0

16,795

Effect of foreign currency

exchange differences

122

(1,600)

1,518

(1)

38

Others

(267)

2,516

(1,045)

21

4

1,229

Balance at 31 March 2019

(67,966)

(254,395)

(39,472)

(1,082)

(159)

(363,074)

Cumulative effect of

accounting change

416

10

346

(772)

Restated balance at 1 April

2019

(67,551)

(254,385)

(39,125)

(1,082)

(159)

(772)

(363,074)

Depreciation expense

(3,776)

(13,869)

(4,025)

0

(7,028)

(28,697)

Impairment losses (ii)

(61)

(223)

(16)

(300)

Disposals (i)

584

7,382

2,072

35

523

10,596

Effect of foreign currency

exchange differences

2,006

7,480

1,428

0

1

269

11,183

Others

324

(151)

(871)

(35)

115

(311)

(930)

Balance at 31 March 2020

(68,473)

(253,767)

(40,537)

(1,082)

(43)

(7,320)

(371,222)

Millions of Yen

Carrying amount

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 1 April 2018

34,710

31,745

24,533

8,598

5,907

105,493

Balance at 31 March 2019

33,451

28,292

24,993

8,151

16,189

111,077

Balance at 31 March 2020

30,478

30,458

24,049

7,778

36,772

22,767

152,302

- 41 -

(Thousands of U.S. Dollars (Note 2))

Cost

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 31 March 2019

931,890

2,597,510

592,342

84,841

150,216

4,356,799

Cumulative effect of

accounting change

(7,169)

(135)

(5,837)

238,016

224,875

Restated balance at 1 April

2019

924,721

2,597,375

586,505

84,841

150,216

238,016

4,581,674

Additions

16,513

22,926

386,166

54,445

485,036

4,986

Acquisitions through business

combinations

300

148

1,065

1,513

Disposals (i)

(16,088)

(73,550)

(21,109)

(346)

(2,761)

(9,361)

(123,216)

Transfer from construction in

progress

29,384

151,848

17,910

(199,142)

Effect of foreign currency

exchange differences

(28,593)

(81,268)

(22,195)

(1,253)

(5,254)

(9,547)

(148,110)

Others

(5,482)

721

9,272

(1,829)

9,058

1,838

13,579

Balance at 31 March 2020

909,227

2,611,640

593,456

81,413

338,283

276,457

4,810,476

(Thousands of U.S. Dollars (Note 2))

Accumulated depreciation and

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

impairment losses

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 31 March 2019

(624,519)

(2,337,546)

(362,692)

(9,940)

(1,458)

(3,336,156)

Cumulative effect of

accounting change

3,822

91

3,183

(7,095)

Restated balance at 1 April

2019

(620,698)

(2,337,455)

(359,509)

(9,940)

(1,458)

(7,095)

(3,336,156)

Depreciation expense

(36,980)

(34,698)

(127,433)

(1)

(64,578)

(263,691)

Impairment losses (ii)

(557)

(2,053)

(150)

(2,760)

Disposals (i)

5,370

67,827

19,042

320

4,804

97,363

Effect of foreign currency

exchange differences

18,429

68,732

13,118

(1)

6

2,469

102,753

Others

2,975

(1,390)

(7,999)

(320)

1,054

(2,857)

(8,537)

Balance at 31 March 2020

(629,178)

(2,331,772)

(372,479)

(9,942)

(400)

(67,258)

(3,411,028)

(Thousands of U.S. Dollars (Note 2))

Carrying amount

Buildings and

Machinery

Tools,

Land

Construction

Right-of-use

Total

structures

and carriers

equipment

in progress

assets

and fixtures

Balance at 31 March 2020

280,049

279,868

220,977

71,471

337,883

209,200

1,399,448

Note:

  1. Gain and loss arising from the sale or disposal of property, plant and equipment for the years ended 31 March 2019 and 2020, are set out in Note 24 "Revenue and expenses (excluding finance income and costs)". Gain and loss on sale of assets held for sale are included in 'gain on sale of property, plant and equipment' and 'loss on sale of property, plant and equipment' in Note 24.
  2. Details of impairment losses are set out in Note 9 "Impairment losses".
  3. Property, plant and equipment under construction are included in "construction in progress" in the table above.

- 42 -

Details of commitments for the acquisition of property, plant and equipment are set out in Note 33 "Commitments for expenditure". There is no borrowing cost capitalised and included in the cost of acquisition of property, plant and equipment.

The following are carrying amounts for property, plant and equipment under Right-of-use assets as at 31 March 2020( Lease assets of finance lease as at 31 March 2019, which were included in each corresponding amount) in the preceding table:

(Millions of Yen

Lease assets of finance lease

Buildings and structures Machinery and carriers

Tools, equipment and

Total

fixtures

Balance at 31 March 2019

5

289

294

(Millions of Yen

Right-of-use assets

Buildings and

Machinery and

Tools,

equipment and

Land

Others

Total

structures

carriers

fixtures

Balance at 1 April 2019

19,238

1,008

1,006

3,869

10

25,131

Balance at 31 March 2020

17,244

947

918

3,654

5

22,767

(Thousands of U.S. Dollars (Note 2))

Right-of-use assets

Buildings and

Machinery and

Tools,

equipment and

Land

Others

Total

structures

carriers

fixtures

Balance at 1 April 2019

176,771

9,263

9,246

35,548

94

230,921

Balance at 31 March 2020

158,450

8,700

8,434

33,571

44

209,200

- 43 -

8,972
1,062
10,034

7. Leases

(Lessee)

As a lessee, the Group leases buildings mainly for offices and stores. Certain lease contracts include renewals or options and escalation clauses (clauses that increase the lease contract amount). There are no restrictions imposed by lease contracts (such as restrictions on dividends, additional borrowings and additional leases).

The fiscal year ended 31 March 2019

Finance lease obligations

Details of finance lease obligations are as follows:

(Millions of Yen)

Minimum lease payments

Present value of minimum

lease payments

As at 31 March 2019

As at 31 March 2019

Amounts payable under finance leases:

Not later than one year

312

285

Later than one year but not later than five years

596

577

Total

908

862

Less future finance charges

(46)

Present value of lease obligations

862

862

Less amount due for settlement within 12 months

285

Amount due for settlement after 12 months

577

The Group has not entered into any new finance lease contracts as part of its policy, except for cases when it concludes that it has a number of advantages of having a lease arrangement in respect of cost reduction or the avoidance of the risk associated with product obsolescence. The average remaining lease term is approximately two to four years as at 31 March 2019.

Operating lease arrangements

Details of minimum lease payments and contingent lease payments for the period under operating lease arrangements are as follows: (Millions of Yen)

For the year ended 31 March 2019

Minimum lease payments Contingent rent

Total

The amounts above are included in the line item 'Other expenses' in the consolidated statement of comprehensive income. Contingent rent, which is determined in rent contracts for stores at shopping malls, is the rent based on the stores' sales amounts.

As at 31 March 2019, the maturity periods of the outstanding commitments under non-cancellable operating leases are as follows: (Millions of Yen)

As at 31 March 2019

Not later than one year

1,770

Later than one year but not later than five years

4,225

Later than five years

763

Total

6,758

Operating lease payments represent rentals payable by the Group for the land used for offices, buildings, etc. The average remaining operating lease terms for those assets as at 31 March 2019, are 26 years and four years, respectively.

- 44 -

The fiscal year ended 31 March 2020

Details of expenses relating to leases are as follows:

(Millions of Yen)

(Thousands of U.S. Dollars (Note 2))

For the year ended 31 March 2020

For the year ended 31 March 2020

Depreciation of right-of-use assets

Buildings and structures

5,967

54,830

Machinery and carriers

564

5,184

Tools, equipment and fixtures

354

3,249

Land

134

1,233

Software

9

82

Total

7,028

64,578

Interest expense on lease liabilities

407

3,740

Expense relating to short-term leases

1,548

14,225

Expense relating to leases of low-value assets

461

4,238

Expense relating to variable lease payments (Note)

1,190

10,935

(Note) The expense is not included in the measurement of lease liabilities.

Expense relating to variable lease payments is linked with sales revenue stipulated in the lease contracts of the store operated in shopping center, etc.

Depreciation of right-of-use assets is included in the line item 'Depreciation and amortisation', interest expense on lease liabilities is in 'Finance costs' and expenses relating to short-term leases, leases of low-value assets and variable lease payments are in 'Other expenses' in the consolidated statement of comprehensive income.

For the year ended 31 March 2020, total cash outflow for leases is 10,746 million yen (98,745 thousand U.S. dollars). A maturity analysis of lease liabilities is set out in Note 21 "Financial instruments"

- 45 -

(Lessor)

Finance leases

The Group leases its products and merchandises as a lessor.

Profit from finance lease contracts is as follows:

(Millions of Yen)

(Thousands of U.S. Dollars (Note

2))

For the year ended 31 March 2020

For the year ended 31 March 2020

Finance income on the net investment in the lease

45

415

A maturity analysis of the receivable under finance lease contracts is as follows:

(Millions of Yen)

(Thousands of U.S. Dollars (Note

2))

As at 31 March 2020

As at 31 March 2020

Not later than one year

371

3,405

Later than one year but not later than two years

319

2,933

Later than two years but not later than three years

223

2,046

Later than three years but not later than four years

146

1,339

Later than four years but not later than five years

70

648

Later than five years

95

874

Total

1,224

11,245

Unearned finance income

(66)

(605)

Net investment on the lease

1,158

10,641

- 46 -

8. Goodwill and intangible assets

The following are the cost, accumulated amortisation, impairment losses and carrying amount of goodwill and intangible assets:

Millions of Yen

Cost

Goodwill

Intangible assets

Software

Technology

Customer

Others (i)

Total

related assets

Balance at 1 April 2018

40,596

21,918

15,316

27,765

6,847

71,846

Additions

1,394

51

1,445

Acquisitions through business

combinations

9,628

1

5,498

4,939

456

10,893

Disposals

(1,090)

(10)

(1,100)

Effect of foreign currency

exchange differences

659

43

526

(43)

51

577

Others

253

77

(773)

68

(629)

Balance at 31 March 2019

51,136

22,342

21,339

31,887

7,462

83,031

Additions

1,288

4

70

1,362

Acquisitions through business

combinations

28

1,473

1,473

Disposals

(341)

(15)

(27)

(3)

(386)

Effect of foreign currency

exchange differences

(1,676)

(607)

(530)

(2,826)

(1,130)

(5,093)

Others

(58)

510

(37)

(107)

15

381

Balance at 31 March 2020

49,430

23,193

20,762

30,400

6,413

80,767

Millions of Yen

Accumulated amortisation and

Goodwill

Intangible assets

impairment losses

Software

Technology

Customer

Others

Total

related assets

Balance at 1 April 2018

(8,704)

(17,647)

(4,390)

(8,791)

(4,155)

(34,983)

Amortisation expense (ii)

(1,246)

(1,276)

(2,521)

(514)

(5,558)

Impairment loss (iii)

(76)

(76)

Disposals

1,016

1,016

Effect of foreign currency

exchange differences

380

(23)

(153)

206

(83)

(52)

Others

32

81

857

(8)

930

Balance at 31 March 2019

(8,293)

(17,896)

(5,818)

(10,249)

(4,760)

(38,723)

Amortisation expense (ii)

(1,136)

(1,575)

(2,460)

(504)

(5,676)

Impairment loss (iii)

Disposals

335

1

335

Effect of foreign currency

exchange differences

909

459

141

1,880

1,008

3,488

Others

35

(448)

59

18

(23)

(395)

Balance at 31 March 2020

(7,348)

(18,687)

(7,194)

(10,811)

(4,280)

(40,971)

- 47 -

Millions of Yen

Carrying amount

Goodwill

Intangible assets

Software

Technology

Customer

Others

Total

related assets

Balance at 1 April 2018

31,892

4,270

10,926

18,974

2,693

36,863

Balance at 31 March 2019

42,843

4,446

15,521

21,639

2,702

44,308

Balance at 31 March 2020

42,082

4,506

13,567

19,589

2,133

39,796

(Thousands of U.S. Dollars (Note 2))

Cost

Goodwill

Intangible assets

Software

Technology

Customer

Others (i)

Total

related assets

Balance at 31 March 2019

469,869

205,296

196,079

293,002

68,564

762,942

Additions

11,832

41

640

12,513

Acquisitions through business

combinations

258

13,533

13,533

Disposals

(3,133)

(137)

(250)

(29)

(3,550)

Effect of foreign currency

exchange differences

(15,397)

(5,573)

(4,870)

(25,968)

(10,387)

(46,798)

Others

(536)

4,687

(343)

(985)

138

3,497

Balance at 31 March 2020

454,194

213,109

190,770

279,332

58,925

742,137

(Thousands of U.S. Dollars (Note 2))

Accumulated amortisation and

Goodwill

Intangible assets

impairment losses

Software

Technology

Customer

Others

Total

related assets

Balance at 31 March 2019

(76,198)

(164,444)

(53,463)

(94,172)

(43,737)

(355,816)

Amortisation expense (ii)

(10,441)

(14,474)

(22,606)

(4,635)

(52,157)

Impairment loss (iii)

Disposals

3,076

6

3,083

Effect of foreign currency

exchange differences

8,356

4,219

1,292

17,277

9,259

32,047

Others

324

(4,115)

540

164

(216)

(3,627)

Balance at 31 March 2020

(67,518)

(171,705)

(66,105)

(99,337)

(39,323)

(376,470)

- 48 -

(Thousands of U.S. Dollars (Note 2))

Carrying amount

Goodwill

Intangible assets

Software

Technology

Customer

Others

Total

related assets

Balance at 31 March 2020

386,677

41,405

124,665

179,996

19,602

365,667

Note:

  1. There were no significant internally generated intangible assets for the years ended 31 March 2019 and 2020.
  2. Amortisation expense is included in the line item 'Depreciation and amortisation' in the consolidated statement of comprehensive income.
  3. Refer to Note 9 "Impairment losses" for details of impairment losses.

No intangible assets have been pledged as collateral to secure the debt. There is no restriction on legal title of these assets. Details of commitments for the acquisition of intangible assets are set out in Note 33 "Commitments for expenditure".

Details of intangible assets in the consolidated statement of financial position are as follows:

As at 31 March 2019

As at 31 March 2020

Carrying amount

Carrying amount

Remaining useful

Carrying amount

(Thousands of

Remaining useful

(Millions of Yen)

lives (Years)

(Millions of Yen)

U.S. Dollars

lives (Years)

(Note 2))

Health Care related

Technology

products

1,997

9

1,683

15,461

8

Medical related

products

13,353

10

11,772

108,166

9

Health Care related

Customer related

products

13,676

11

12,368

113,647

10

assets

Medical related

products

6,088

13

5,292

48,622

12

- 49 -

9. Impairment losses

The following are the details of impairment losses recognised.

Impairment losses have been included in the line item 'Impairment losses' in the consolidated statement of comprehensive income.

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars (Note 2))

For the year ended 31 March 2019

For the year ended 31 March 2020

For the year ended 31 March 2020

Buildings and structures

51

61

557

Machinery and equipment

370

223

2,053

Tools, equipment and fixtures

360

16

150

Land

128

Construction in progress

113

Total impairment losses on

property, plant and equipment

1,023

300

2,760

Software

76

Total impairment losses on

intangible assets

76

Total impairment losses

1,099

300

2,760

(1) Cash-generating units

The Group identifies each strategic business unit ("SBU") as a cash-generating unit for impairment testing purposes. Each business unit has been set based on the production and sale of product lines. For any asset expected to be sold or disposed, or any idle asset, the asset is individually tested for impairment.

  1. Impairment losses on assets in business units For the year ended 31 March 2019
    No impairment losses on assets were recognised in business units.

For the year ended 31 March 2020

No impairment losses on assets were recognised in business units.

- 50 -

(3) Impairment losses on idle assets

For the year ended 31 March 2019, the carrying amount of the related assets, which were not expected to be used in the future due to business restructuring, was written down to the recoverable amount which was measured at fair value less related selling costs, and the corresponding impairment loss was recognised.

Impairment losses were recognised as follows for the year ended 31 March 2019:

(Millions of Yen)

Impairment losses

Life Care

Buildings and structures

35

Machinery and carriers

105

Tools, equipment and fixtures

360

Construction in progress

113

Software

76

Total Life Care

690

Information Technology

Buildings and structures

16

Machinery and carriers

265

Total Information Technology

281

Corporate

Land

128

Total Corporate

128

Total

1,099

For the year ended 31 March 2020, the carrying amount of the related assets, which were not expected to be used in the future due to business restructuring, was written down to the recoverable amount which was measured at fair value less related selling costs, and the corresponding impairment loss was recognised.

Impairment losses were recognised as follows for the year ended 31 March 2020:

(Millions of Yen)

(Thousands of U.S. Dollars (Note 2))

Impairment losses

Impairment losses

Life Care

Tools, equipment and fixtures

1

6

Total Life Care

1

6

Information Technology

Buildings and structures

61

557

Machinery and carriers

223

2,053

Tools, equipment and fixtures

16

144

Total Information Technology

300

2,754

Total

300

2,760

- 51 -

Japan Americas Europe Asia
Total
Japan Americas Europe Asia
Total
Japan Americas Europe Asia
Total
(4) Goodwill allocated to cash-generatingunits
When the recoverable amount of the goodwill specifically associated with a cash-generatingunit is lower than the carrying amount of such goodwill, an impairment loss is recognised and the goodwill is written down to the recoverable amount. The recoverable amount of goodwill allocated to cash-generatingunits was measured at the value in use and it was determined using cash flow projections based on the financial budgets that had been approved by the Group's management and applying a discount rate of 5% to 19% per annum which is the cash-generatingunits' pre-taxWACC. Cash flow projections during the budgeted period are based on the expected gross margins and taking into account inflation. The cash flows beyond the budget period have been extrapolated using a steady annum growth rate which is the projected long-termaverage growth rate for the main products market. Management believes that any reasonably possible change in the key assumptions (e.g., profit ratio, inflation, the projected long-termaverage growth rate and the before tax, WACC) on which the recoverable amount is based would not cause the aggregate carrying amount to exceed the aggregate recoverable amount of the cash-generatingunit.
The carrying amount of goodwill was allocated to the cash-generatingunits as follows:
Millions of Yen
As at 31 March 2019

Life Care

Other

Health Care related

Medical related products

Other

Total

products

Eyeglass lenses

Medical accessories

1,524

791

733

26,303

12,824

39,128

623

801

525

1,950

242

242

27,960

14,358

525

42,843

Millions of Yen

As at 31 March 2020

Life Care

Other

Health Care related

Medical related products

Other

Total

products

Eyeglass lenses

Medical accessories

849

733

1,582

25,444

12,981

38,425

551

769

504

1,823

252

252

27,096

14,482

504

42,082

(Thousands of U.S. Dollars (Note 2))

As at 31 March 2020

Life Care

Other

Health Care related

Medical related products

Other

Total

products

Eyeglass lenses

Medical accessories

14,536

7,803

6,733

233,796

119,278

353,074

5,059

7,061

4,633

16,753

2,314

2,314

248,972

133,072

4,633

386,677

- 52 -

10. Investments in associates

A summary of the Group's associates, which are not individually significant, is as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at / for the year

As at / for the year

As at / for the year

ended 31 March 2019

ended 31 March 2020

ended 31 March 2020

The Group's share of net income (loss)

(1,113)

(1,652)

(15,182)

The Group's share of other comprehensive income (loss)

(16)

76

701

The Group's share of comprehensive income (loss)

(1,129)

(1,576)

(14,481)

The Group's share of net assets

349

1,007

9,250

Details of the Group's major associates, which are not individually significant, are as follows:

Place of

Ownership interest (%)

Name of associate

Principal activity

incorporation and

Segment

As at

As at

operation

31 March 2019

31 March 2020

AVANSTRATE, INC.

Production and

JAPAN

Corporate

46.6

46.6

sale of glass

substrate for thin

film transistor

(TFT) liquid

crystal

EYE-Q VISION PRIVATE

Medical services

INDIA

Corporate

24.3

24.3

LIMITED

related to

ophthalmology

HTK LENTES OFTALMICAS

Sale of optical

BRAZIL

Life Care

37.6

37.6

LTDA

lens

JIASHAN CANDEO OPTICAL

Production and

CHINA

Information

49.0

49.0

GLASS CO., LTD.

sale of special

Technology

glass, such as

coloured glass

The Group's unrecognised share of loss on associates is as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at / for the year

As at / for the year

As at / for the year

ended 31 March 2019

ended 31 March 2020

ended 31 March 2020

The Group's unrecognised share of net loss

608

6,392

58,736

The Group's unrecognised share of accumulated net loss

8,002

14,394

132,262

- 53 -

11. Deferred taxes and income taxes

(1) Deferred taxes

Details of deferred tax assets and liabilities are as follows:

Millions of Yen

Recognised

As at

Recognised in

in other

Business

As at

1 April 2018

profit or loss

comprehensive

combinations

31 March 2019

income

Temporary differences

Enterprise tax payable

573

(221)

353

Write-down of inventories

1,033

345

132

1,511

Allowance for doubtful

588

149

737

accounts

Provisions

805

12

817

Accrued expenses

3,665

566

274

4,504

Unrealised profit on inventories

2,521

666

3,187

Depreciation and amortisation

1,349

88

1,437

Impairment losses

546

202

748

Exchange differences on

3

124

127

translating foreign operations

Others

3,184

(1,584)

(10)

1,590

Subtotal

14,267

223

114

406

15,010

Undistributed retained earnings

(2,192)

(861)

(3,053)

of subsidiaries

Depreciation and amortisation

(6,154)

767

(3,001)

(8,389)

Financial assets measured at

(164)

(135)

(300)

fair value through other

comprehensive income

Others

(421)

(23)

(444)

Subtotal

(8,932)

(117)

(135)

(3,001)

(12,185)

Tax loss carryforwards and tax

credits

Tax loss carryforwards

2,716

(324)

2,392

Tax credits

8

21

29

Subtotal

2,724

(303)

2,421

Total

8,059

(197)

(21)

(2,595)

5,246

Note:

The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred tax and income taxes" (2) Income taxes is due to foreign exchange fluctuations.

- 54 -

Millions of Yen

Cumulative

As at

Recognised

As at

effect of

Recognised in

in other

As at

1 April 2019

1 April 2019

accounting

profit or loss

comprehensive

31 March 2020

(Restated)

change

income

Temporary differences

Enterprise tax payable

353

353

340

693

Write-down of inventories

1,511

1,511

(61)

1,450

Allowance for doubtful

737

737

(326)

411

accounts

Provisions

817

817

330

1,147

Accrued expenses

4,504

4,504

(929)

3,575

Unrealised profit on inventories

3,187

3,187

(300)

2,887

Depreciation and amortisation

1,437

1,437

690

2,126

Impairment losses

748

748

(156)

592

Exchange differences on

127

127

75

(203)

translating foreign operations

Lease obligations

2,772

2,772

2,772

Others

1,590

1,590

951

22

2,563

Subtotal

15,010

2,772

17,783

615

(181)

18,216

Undistributed retained earnings

(3,053)

(3,053)

(799)

(3,852)

of subsidiaries

Depreciation and amortisation

(8,389)

(8,389)

70

(8,319)

Lease obligations

(2,948)

(2,948)

(2,948)

Financial assets measured at

(300)

(300)

299

(234)

(234)

fair value through other

comprehensive income

Others

(444)

(444)

(242)

(686)

Subtotal

(12,185)

(2,948)

(15,134)

(672)

(234)

(16,040)

Tax loss carryforwards and tax

credits

Tax loss carryforwards

2,392

2,392

(477)

1,915

Tax credits

29

29

18

47

Subtotal

2,421

2,421

(459)

1,962

Total

5,246

(176)

5,070

(516)

(415)

4,139

Note:

The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred taxes and income taxes" (2) Income taxes is due to foreign exchange fluctuations.

- 55 -

(Thousands of U.S. Dollars (Note 2))

Cumulative

As at

Recognised

As at

effect of

Recognised in

in other

As at

1 April 2019

1 April 2019

accounting

profit or loss

comprehensive

31 March 2020

(Restated)

change

income

Temporary differences

Enterprise tax payable

3,240

3,240

3,123

6,363

Write-down of inventories

13,882

13,882

(558)

13,324

Allowance for doubtful

6,771

6,771

(2,996)

3,775

accounts

Provisions

7,508

7,508

3,031

10,538

Accrued expenses

41,389

41,389

(8,536)

32,853

Unrealised profit on inventories

29,283

29,283

(2,754)

26,529

Depreciation and amortisation

13,200

13,200

6,338

19,538

Impairment losses

6,873

6,873

(1,430)

5,443

Exchange differences on

1,170

1,170

693

(1,863)

translating foreign operations

Lease obligations

25,475

25,475

25,475

Others

14,611

14,611

8,736

200

23,546

Subtotal

137,926

25,475

163,401

5,647

(1,663)

167,385

Undistributed retained earnings

(28,053)

(28,053)

(7,342)

(35,395)

of subsidiaries

Depreciation and amortisation

(77,082)

(77,082)

643

(76,439)

Financial assets measured at

(2,752)

(2,752)

2,749

(2,149)

(2,153)

fair value through other

comprehensive income

Lease obligations

(27,090)

(27,090)

(27,090)

Others

(4,080)

(4,080)

(2,228)

(6,308)

Subtotal

(111,967)

(27,090)

(139,056)

(6,178)

(2,149)

(147,383)

Tax loss carryforwards and tax

credits

Tax loss carryforwards

21,978

21,978

(4,383)

17,595

Tax credits

264

264

169

432

Subtotal

22,242

22,242

(4,214)

18,027

Total

48,201

(1,615)

46,586

(4,745)

(3,812)

38,029

Note:

The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred taxes and income taxes" (2) Income taxes is due to foreign exchange fluctuations.

- 56 -

Tax loss carryforwards and deductible temporary differences for which deferred tax assets have not been recognised are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Tax loss carryforwards

13,130

11,120

102,179

Deductible temporary differences

4,128

4,226

38,829

Total

17,258

15,346

141,008

The expiration date and amounts of tax loss carryforwards for which deferred tax assets are not recognised are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Year 1

1,890

1,329

12,216

Year 2

1,750

611

5,614

Year 3

1,134

820

7,535

Year 4

513

403

3,706

Year 5 or later

7,843

7,956

73,107

Total

13,130

11,120

102,177

The aggregate amounts of temporary differences associated with undistributed retained earnings of the subsidiaries for which deferred tax liabilities have not been recognised at 31 March 2019 and 2020, were 322,017 million yen and 327,573 million yen (3,009,954 thousand U.S. dollars), respectively. No liability has been recognised in respect of these differences because the Group is in a position to control the timing of the reversal of the temporary differences and it is probable that such differences will not reverse in the foreseeable future.

(2) Income taxes

In Japan, the normal effective statutory tax rates are 30.5% for each of the years ended 31 March 2019 and 2020.

Current or deferred taxes in other tax jurisdictions are calculated by the tax rates generally applied to those tax jurisdictions. Details of current tax expense and deferred tax expense are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Current tax expense: (i)

Current year

22,915

31,948

293,560

Prior years

(690)

454

4,169

Total current tax expense

22,225

32,402

297,729

Deferred tax expense: (ii)

Origination and reversal of temporary difference

318

252

2,314

Changes in tax rates

41

27

251

Total deferred tax expense

359

279

2,566

Total income tax expense

22,584

32,681

300,295

Continuing operations

22,584

32,681

300,295

Discontinued operations

Note:

  1. "Current tax expense" includes previously unrecognised tax benefits from tax loss carryforwards, tax credits and deductible temporary differences. These benefits were 194 million yen and 15 million yen (142 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.

- 57 -

  1. "Deferred tax expense" includes previously unrecognised tax benefits from tax loss carryforwards, tax credits, deductible temporary differences, and expenses or benefits arising from write-downs of deferred tax assets or the reversal of previous write- downs of deferred tax assets. These effects increased the deferred tax expense by 471 million yen and 660 million yen (6,061 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
  2. On 26 June 2013, the Company received a reassessment notice from the Tokyo Regional Taxation Bureau ("TRTB") for additional tax on the transfer pricing taxation of transactions with overseas subsidiaries that develop and manufacture electronics- related products for the five financial years ended 31 March 2007 to 2011. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law.
    On 29 March 2018, the Company received a written verdict from the National Tax Tribunal (the "Tribunal"), which partially cancels the reassessments. The Company disagrees with the remaining findings of the Tribunal's verdict that maintains portions of the reassessment and the Company expects to appeal the findings in court to seek cancellation of all the reassessments by the tax authorities. Consequently, the paid amount of 7,916 million yen (72,740 thousand U.S. dollars) is included in "Other current assets" as a suspense payment.
    On 27 June 2018, the Company received a reassessment notice from TRTB for additional taxes on the transfer pricing taxation of transactions with overseas subsidiaries that developed and manufactured electronics-related products for the three financial years ended 31 March 2012, 2013 and 2014. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law. The additional tax assessment of 5,174 million yen (47,544 thousand U.S. dollars) is included in "Other current assets" as a suspense payment.

A reconciliation of the normal effective statutory tax rate with the actual tax rate is as follows. The actual tax rate represents the ratio of income tax expense and profit before tax from continuing operations.

For the year ended

For the year ended

31 March 2019

31 March 2020

Effective statutory tax rate

30.5%

30.5%

Expenses not deductible for tax purposes

0.5%

1.1%

Income not taxable for tax purposes

(3.1)%

(0.6)%

Effect of unrecognised deferred tax assets

0.3%

0.1%

Impact of different tax rates applied to overseas subsidiaries

(15.2)%

(12.0)%

Profits and losses on investments in associates

0.2%

0.1%

Adjustment on deferred tax assets and liabilities due to the change of corporate tax

rate

0.0%

(0.0)%

Tax rate difference due to the elimination of unrealised profit on inventories

0.2%

(0.2)%

Increase/decrease in deferred tax liabilities related to undistributed earnings of foreign

subsidiaries

0.6%

0.5%

Prior year income taxes

(0.5)%

0.3%

Foreign withholding tax arising from dividends from subsidiaries

1.0%

0.0%

Others

1.1%

2.4%

Actual tax rate

15.6%

22.2%

There was no effect on income tax resulting from dividends paid to shareholders.

- 58 -

12. Other financial assets and liabilities

(1) Details of other financial assets and liabilities

Details of other financial assets and liabilities are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Other financial assets

Other financial assets measured at amortised cost

17,370

16,490

151,518

FVTOCI financial assets

29,863

30,789

282,906

Total

47,233

47,278

434,424

Total non-current assets (long-term financial

assets)

44,103

45,975

422,448

Total current assets (other short-term financial

assets)

3,131

1,303

11,976

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Other financial liabilities

FVTPL financial liabilities

3,082

542

4,976

Other financial liabilities measured at amortised

cost

8,500

26,205

240,785

Total

11,582

26,746

245,761

Total non-current liabilities (other long-term

financial liabilities)

10,936

23,923

219,817

Total current liabilities (other short-term financial

liabilities)

646

2,824

25,944

(2) Details of FVTOCI financial assets

Details of FVTOCI financial assets are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

KIOXIA Holdings Corporation

27,000

28,200

259,123

The asset above is designated as FVTOCI because its profit and loss is not related to the business profit and loss, while there is a possibility of selling it in the future.

- 59 -

- 60 -

(3) Derecognition of FVTOCI financial assets

The Group derecognises FVTOCI financial assets when they are partially sold, considering the capital efficiency, reconsideration of business relationships and so on.

Details of fair value and cumulative gain or loss in other comprehensive income at the time of selling in the year ended 31 March 2019 and 2020 are as follows:

Fair value

Cumulative gain or loss

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

Dollars (Note 2))

For the year ended

For the year ended

For the year ended

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

31 March 2019

31 March 2020

31 March 2020

11

357

3,280

6

88

804

Cumulative gain or loss in other comprehensive income is transferred to retained earnings when FVTOCI assets are derecognised. The amount of cumulative other comprehensive income or loss (after deduction of tax) which was transferred to retained earnings were 6 million yen and 61 million yen (559 thousand U.S. dollars) in the year ended 31 March 2019 and 2020.

Details of dividends income recognised from equity instruments are as follows:

Derecognised investment

Investment held as at 31 March 2020

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

Dollars (Note 2))

For the year ended

For the year ended

For the year ended

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

31 March 2019

31 March 2020

31 March 2020

0

10

10

92

13. Other assets and liabilities

Details of other assets and liabilities are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Non-current: Other assets

Long-term prepaid expenses

2,187

412

3,784

Others

773

274

2,513

Total

2,960

685

6,297

Current: Other assets

Suspense payment (Note)

13,090

13,090

120,283

Prepaid expenses

4,131

2,368

21,762

Refundable consumption taxes

1,406

1,457

13,383

Others

2,319

2,992

27,488

Total

20,946

19,907

182,918

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Non-current: Other liabilities

Deposit received and long-term advance

2,303

1,363

12,526

revenue, etc.

Total

2,303

1,363

12,526

Current: Other liabilities

Accrued salary/bonus/vacation pay

16,357

15,894

146,040

Other accrued expenses

17,793

16,504

151,653

Advance received/deferred revenue

5,356

4,140

38,042

Accrued consumption taxes

1,897

1,536

14,115

Others

2,769

2,107

19,359

Total

44,171

40,181

369,209

Note:

On 26 June 2013, the Company received a reassessment notice from the Tokyo Regional Taxation Bureau (‟TRTB") for additional tax on the transfer pricing taxation of transactions with overseas subsidiaries that develop and manufacture electronics- related products for the five financial years ended 31 March 2007 to 2011. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law.

On 29 March 2018, the Company received a written verdict from the National Tax Tribunal (the "Tribunal"), which partially cancels the reassessments. The Company disagrees with the remaining findings of the Tribunal's verdict that maintains portions of the reassessment and the Company expects to appeal the findings in court to seek cancellation of all the reassessments by the tax authorities.

Consequently, the paid amount of 7,916 million yen is included in "Other current assets" as a suspense payment.

On 27 June 2018, the Company received a reassessment notice from the TRTB for additional taxes on the transfer pricing taxation of transactions with overseas subsidiaries that developed and manufactured electronics-related products for the three financial years ended 31 March 2012, 2013 and 2014. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law. The additional tax assessment of 5,174 million yen is included in ‟Other current assets" as a suspense payment.

- 61 -

14. Inventories

Details of inventories are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Goods and products

40,330

39,042

358,744

Work in progress

8,566

7,791

71,586

Raw materials

18,953

18,506

170,048

Supplies

11,124

12,791

117,532

Total

78,973

78,130

717,910

Inventories expected to be sold

7

4

35

after more than 12 months

The cost of inventories recognised as an expense during the years ended 31 March 2019 and 2020, was 250,891 million yen and 252,630 million yen (2,321,324 thousand U.S. dollars), respectively.

The cost of inventories recognised as an expense in respect of write-down and the reversal of such write-down is as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Amount of write-down

1,756

1,960

18,008

Amount of reversal of write-

down

The reversal of write-down was due to an increase in net realisable value, as a result of an increase in new orders with positive sales activities.

15. Trade and other receivables

Details of trade and other receivables are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Accounts receivable

104,305

97,422

895,180

Notes receivable and

6,908

5,694

52,322

electronically recorded

monetary claims-operating

Other receivables

2,694

3,078

28,280

Allowance for doubtful accounts

(3,061)

(2,855)

(26,235)

Total

110,847

103,339

949,547

The credit terms for customers are set between 90 days and 120 days on average.

Refer to Note 21 "Financial instruments" for credit risk management and fair value of trade and other receivables.

- 62 -

16. Interest-bearing debt

Details of interest-bearing debt are as follows:

(Millions of

(Millions of

(Thousands of

Average

Yen)

Yen)

U.S. Dollars

interest rate

Due

(Note 2))

(%)

As at 31 March As at 31 March As at 31 March

(i)

2019

2020

2020

Long-term bank loans (excluding current portion)

327

234

2,154

2022-2032

Current portion of long-term bank loans

1

19

175

Short-term bank loans

1,648

864

7,941

1.48%

Long-term lease obligations

577

14,237

130,823

20222049

Short-term lease obligations

285

6,610

60,741

Total interest-bearing debt

2,838

21,966

201,834

Total non-current debt

904

14,472

132,977

Total current debt

1,934

7,494

68,857

Note:

(i) Interest rates are based on the weighted-average rates that applied to the balances at the end of each fiscal year.

The obligations under leases are secured by the leased assets for which the lessor has ownership. There is no debt with covenants as at 31 March 2020.

Details of the remaining contractual maturity for long-term borrowings and its fair values are set out in Note 21 "Financial instruments".

- 63 -

The changes in liabilities arising from financial activities are as follows:

(Millions of Yen)

Non-cash changes

Exchange

As at 31 March

As at 1 April 2018

Cash flow

Change of scope

differences on

Others

2019

of consolidation

translation of

foreign operations

Short-term bank

1,658

(10)

1,648

loans

Long-term bank

9

(20)

340

(0)

328

loans

Bond

14

(14)

Finance lease

672

(251)

(35)

476

862

obligations

Total

2,353

(284)

340

(46)

476

2,838

(Millions of Yen)

Non-cash changes

Change in

As at 1 April

Exchange

As at 1 April

accounting

2019

Cash flow

differences on

As at 31 March

2019

policy

(after

translation of

Others

2020

(IFRS 16)

adjustment)

foreign

operations

Short-term bank

1,648

1,648

(775)

(9)

864

loans

Long-term bank

328

328

(134)

59

253

loans

Lease obligations

862

21,375

22,237

(7,547)

(630)

6,787

20,848

Total

2,838

21,375

24,214

(8,456)

(579)

6,787

21,966

(Thousands of U.S. Dollars (Note 2)

Non-cash changes

Change in

As at 1 April

Exchange

As at 1 April

accounting

2019

Cash flow

differences on

As at 31 March

2019

policy

(after

translation of

Others

2020

(IFRS 16)

adjustment)

foreign

operations

Short-term bank

15,143

15,143

(7,123)

(79)

7,941

loans

Long-term bank

3,015

3,015

(1,231)

545

2,329

loans

Lease obligations

7,922

196,410

204,332

(69,346)

(5,789)

62,367

191,564

Total

26,080

196,410

222,490

(77,700)

(5,323)

62,367

201,834

- 64 -

17. Retirement benefit plans

The Group has contributory defined contribution plans and defined benefit plans, and non-contributory defined benefit plans. The accounting policies adopted by the Group for retirement benefit plans are stated in Note 3 "Significant accounting policies (19) Retirement benefit costs".

The Company and its domestic subsidiaries mainly have defined contribution plans. Overseas subsidiaries have benefit plans required by the local laws and regulations of each country. Unless a defined benefit plan is required by the laws of the country in which the overseas subsidiaries operate, a defined contribution plan has been put into place. The plan in the U.K. represents a substantial portion of the pension plans of the Group, where it is the closed plan that stopped new registrations. Management believes that general risks, such as investment, credit and salary risks are not significant in the plan.

The Group does not have retirement benefit plans other than pension plans and lump-sum retirement allowances.

(1) Defined benefit plans

The amounts included in the consolidated statement of financial position arising from the Group's obligations in respect of its defined benefit plans are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Present value of funded defined benefit obligation

6,610

7,036

64,651

Fair value of plan assets

(3,907)

(3,889)

(35,736)

Total

2,704

3,147

28,915

Effect of changes to the asset ceiling

66

56

513

Net liability arising from defined benefit plans

obligations

2,770

3,203

29,428

Balance in the consolidated statement of financial

position

Liability

2,770

3,203

29,428

Asset (Other non-current assets)

- 65 -

Amounts recognised in the consolidated statement of comprehensive income in respect of these defined benefit plans are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Service cost

Current service cost

626

1,192

10,954

Past service cost

(274)

(2,514)

Net interest expense

36

47

432

Components of defined benefit costs

662

966

8,872

recognised in profit or loss

Remeasurement of net defined benefit

liability

Return on plan assets

138

81

743

Actuarial gains and losses arising from

(8)

(24)

(216)

changes in demographic assumptions

Actuarial gains and losses arising from

158

(105)

(964)

changes in financial assumptions

Actuarial gains and losses arising from

(58)

102

934

experience adjustments

Adjustments for restrictions on the

61

(5)

(42)

defined benefit asset

Components of defined benefit costs

293

50

456

recognised in other comprehensive

income

Total

955

1,015

9,328

Service cost and net interest expense are included in 'Employee benefits expense' and 'Finance cost' in the consolidated statement of comprehensive income.

Movements in the present value of the defined benefit obligations are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Beginning balance

6,033

6,610

60,738

Current service cost

626

1,192

10,954

Interest cost

125

116

1,065

Remeasurement (gains)/losses

Actuarial gains and losses arising from

(8)

(24)

(216)

changes in demographic assumptions

Actuarial gains and losses arising from

158

(105)

(964)

changes in financial assumptions

Actuarial gains and losses arising from

(58)

102

934

experience adjustments

Past service cost

(274)

(2,514)

Decrease due to settlements

(12)

(111)

Benefits paid

(267)

(190)

(1,743)

Effect of foreign currency exchange

1

(380)

(3,492)

differences

Ending balance

6,610

7,036

64,651

Movements in the present value of the plan assets are as follows:

- 66 -

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Beginning balance

3,906

3,907

35,896

Interest income

89

632

69

Remeasurement gain (loss)

Return on plan assets (excluding amounts

(138)

(81)

(743)

included in net interest expense)

Contributions from the employer

344

283

2,603

Benefits paid

(210)

(212)

(1,950)

Effect of foreign currency exchange

(84)

(76)

(703)

differences

Ending balance

3,907

3,889

35,736

Movements in the effect of changes to the asset ceiling are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Beginning balance

66

606

Remeasurement gain (loss)

Effect of changes in the asset ceiling

61

(5)

(42)

Effect of foreign currency exchange

differences

5

(6)

(51)

Ending balance

66

56

513

The fair values of major categories of plan assets as at 31 March 2019 and 2020, are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Cash and cash equivalents

959

1,240

11,397

Equity instruments - Foreign equity

1,966

1,768

16,244

instruments

Debt instruments - Foreign governmental

181

167

1,539

bonds

Debt instruments - Foreign bonds

779

688

6,324

Others

20

25

232

Total

3,907

3,889

35,736

The fair values of financial instruments are measured at quoted market price in active markets. No transferable instrument is included in plan assets.

The principal assumptions used for the purposes of the actuarial valuations were as follows:

As at 31 March 2019

As at 31 March 2020

Discount rate

2.3%

2.4%

The Group believes there is no material impact on operating results, financial positions and cash flows due to the defined benefit plan of the Group, including the amount, timing and uncertainly of future cash flows.

- 67 -

(2) Defined contribution plans

The total expense recognised was 2,416 million yen and 2,371 million yen (21,787 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.

(3) Severance payments

Under certain circumstances (such as retirement before the predetermined retirement date), additional payments are made upon retirement. The total expense recognised was 1,924 million yen and 1,770 million yen (16,264 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.

- 68 -

18. Provisions

Details of provisions are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Asset retirement obligation

2,620

2,559

23,512

Warranties provision

1,249

1,214

11,157

Total

3,868

3,773

34,669

Non-current liabilities

2,607

2,539

23,327

Current liabilities

1,261

1,234

11,342

An analysis of the change in provisions is as follows:

(Millions of Yen)

Asset retirement obligation

Warranties provision

Total

Balance at 1 April 2019

1,249

3,868

2,620

Provision for the year

77

908

832

Acquisitions through business combinations

20

20

Interest cost associated with passage of time

18

18

Reduction resulting from settlement for the year

(146)

(822)

(968)

Effect of foreign currency exchange differences

(28)

(44)

(73)

Balance at 31 March 2020

2,559

1,214

3,773

(Thousands of U.S. Dollars (Note 2))

Asset retirement obligation

Warranties provision

Total

Balance at 1 April 2019

11,473

35,542

24,070

Provision for the year

705

7,642

8,347

Acquisitions through business combinations

182

182

Interest cost associated with passage of time

161

161

Reduction resulting from settlement for the year

(1,343)

(7,553)

(8,896)

Effect of foreign currency exchange differences

(262)

(405)

(667)

Balance at 31 March 2020

23,512

11,157

34,669

Note:

Refer to Note 3 "Significant accounting policies (20) Provisions and contingent liabilities assumed in a business combination" for details of each provision.

- 69 -

19. Trade and other payables

Details of trade and other payables are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Accounts payable

29,871

31,296

287,571

Notes payable, trade

6,903

5,943

54,605

Processing cost payable

849

830

7,629

Other payables

16,823

23,968

220,232

Notes payable for capital investment

442

858

7,885

Total

54,887

62,895

577,922

Trade notes payable are due 120 days on average.

Accounts payable are due 30 to 60 days from the invoice date in Asia except for Japan, and due 90 to 120 days from the invoice date in Japan. Accounts payable in Europe and U.S.A. are mainly payables related to intragroup transactions; thus, upon consolidation, these trade accounts payable are eliminated. The Group arranges cash pooling for Japan, Europe and U.S.A. to ensure that all payables are paid within the pre-agreed credit terms.

- 70 -

20. Share capital and other equity items

(1) Share capital and capital reserves

Number of

Number of issued

Number of

Share capital

Capital

Share capital

Capital

authorised shares

shares

outstanding shares

reserves

reserves

(Ordinary shares

(Ordinary shares

(Ordinary shares

(Millions of

(Millions of

(Thousands of (Thousands of

with no par valuewith no par valuewith no par value

Yen)

Yen)

U.S. Dollars

U.S. Dollars

(Note 2))

(Note 2))

Balance at

1 April 2018

1,250,519,400

381,436,420

379,514,346

6,264

15,899

57,560

146,087

Increase (ii)

453,257

Balance at

31 March 2019

1,250,519,400

381,436,420

379,967,603

6,264

15,899

57,560

146,087

Decrease (i), (ii)

3,085,200

4,967,819

Balance at

31 March 2020

1,250,519,400

378,351,220

374,999,784

6,264

15,899

57,560

146,087

Note:

  1. Decrease in number of issued shares is due to cancellation of treasury shares.
  2. Increase or decrease in number of outstanding shares is due to increase or decrease in treasury shares.
  1. Treasury shares and other capital reserves
    Treasury shares

Numbers of shares

Amount

(Millions of Yen)

Balance at 1 April 2018

1,922,074

10,886

Repurchase of odd-lot shares

347

2

Disposal of odd-lot shares

(4)

(0)

Decrease on exercise of stock options

(453,600)

(2,569)

Balance at 31 March 2019

1,468,817

8,319

Repurchase of treasury shares

5,295,700

44,256

Cancellation of treasury shares

(3,085,200)

(22,308)

Repurchase of odd-lot shares

519

5

Decrease on exercise of stock options

(328,400)

(2,309)

Balance at 31 March 2020

3,351,436

27,963

- 71 -

Amount

Numbers of shares

(Thousands of U.S. Dollars

(Note 2))

Balance at 31 March 2019

1,468,817

76,441

Repurchase of treasury shares

5,295,700

406,656

Cancellation of treasury shares

(3,085,200)

(204,982)

Repurchase of odd-lot shares

519

45

Decrease on exercise of stock options

(328,400)

(21,214)

Balance at 31 March 2020

3,351,436

256,945

Other capital reserves

Gain (loss) on

disposal of treasury

Stock option (i)

Others

Total

shares

(Millions of Yen)

(Millions of Yen)

(Millions of Yen)

(Millions of Yen)

Balance at 1 April 2018

(8,672)

3,114

(1,102)

(6,660)

Disposal of treasury shares

(600)

(370)

(969)

Share-based payments (i)

195

195

Balance at 31 March 2019

(9,272)

2,940

(1,102)

(7,434)

Repurchase of treasury shares

(22)

(22)

Disposal of treasury shares

(771)

(261)

(1,032)

Share-based payments (i)

125

125

Change in non-controlling interests (ii)

(65)

(65)

Balance at 31 March 2020

(10,043)

2,804

(1,189)

(8,428)

Gain (loss) on

disposal of treasury

Stock option (i)

Others

Total

shares

(Thousands of U.S.

(Thousands of U.S.

(Thousands of U.S.

(Thousands of U.S.

Dollars (Note 2))

Dollars (Note 2))

Dollars (Note 2))

Dollars (Note 2))

Balance at 31 March 2019

(85,197)

27,012

(10,126)

(68,311)

Repurchase of treasury shares

(203)

(203)

Disposal of treasury shares

(7,082)

(2,400)

(9,483)

Share-based payments (i)

1,153

1,153

Change in non-controlling interests (ii)

(597)

(597)

Balance at 31 March 2020

(92,280)

25,764

(10,926)

(77,442)

  1. Refer to Note 22 "Share-based payments" for details of stock options.
  2. The Group acquired 5.0% of outstanding shares in HOYA LENS GUANGZHOU LTD. As a result, the ownership interest of the Group increased to 100%. 65 million yen (597 thousand U.S. dollars), the difference between the decrease of non-controlling interests (i.e., proportional interests of the carrying amount of the net assets) and the consideration paid for the shares is included in 'Other capital reserves' in the consolidated statement of financial position.

- 72 -

(3) Retained earnings and dividends

Amount

(Millions of Yen)

Balance at 1 April 2018

529,818

Profit for the year (attributable to owners of the Company)

122,103

Dividends

(34,164)

Transfer to retained earnings

(297)

Balance at 31 March 2019

617,459

Cumulative effect of change in accounting policy

533

Profit for the year (attributable to owners of the Company)

114,406

Cancellation of treasury shares

(22,308)

Dividends

(34,064)

Transfer to retained earnings from other comprehensive income

32

Balance at 31 March 2020

676,058

Amount

(Thousands of U.S. Dollars (Note 2))

Balance at 31 March 2019

5,673,614

Cumulative effect of change in accounting policy

4,895

Profit for the year (attributable to owners of the Company)

1,051,239

Cancellation of treasury shares

(204,982)

Dividends

(313,006)

Transfer to retained earnings from other comprehensive income

296

Balance at 31 March 2020

6,212,056

Details of dividends are as follows:

Dividends per

Dividends per

Total dividends

Total dividends

Date of resolution

share

share

(Millions of

(Thousands of

Record date

Effective date

(U.S. Dollars

U.S. Dollars

(Yen)

Yen)

(Note 2))

(Note 2))

24 May 2018

45

0.41

17,078

156,925

31 March 2018

1 June 2018

31 October 2018

45

0.41

17,086

157,000

30 September 2018

30 November 2018

23 May 2019

45

0.41

17,099

157,112

31 March 2019

3 June 2019

29 October 2019

45

0.41

16,966

155,894

30 September 2019

29 November 2019

20 May 2020

45

0.41

16,875

155,058

31 March 2020

8 June 2020

Dividends payable are included in the line item 'Other short-term financial liabilities' in the consolidated statement of financial position.

- 73 -

(4) Non-controlling interests

Amount

(Millions of Yen)

Balance at 1 April 2018

4,484

Profit for the year, attributable to non-controlling interests

(31)

Other comprehensive income

(140)

Dividends

(30)

Increase due to acquisition of subsidiaries

202

Increase

67

Balance at 31 March 2019

4,552

Profit for the year, attributable to non-controlling interests

181

Other comprehensive income

(220)

Increase due to establishment of subsidiaries

187

Decrease due to acquisition of non-controlling interests

(84)

Put option granted to non-controlling interests, etc.(i)

(20,392)

Balance at 31 March 2020

(15,777)

Amount

(Thousands of U.S. Dollars (Note 2))

Balance at 31 March 2019

41,824

Profit for the year, attributable to non-controlling interests

1,659

Other comprehensive income

(2,019)

Increase due to establishment of subsidiaries

1,715

Decrease due to acquisition of non-controlling interests

(775)

Put option granted to non-controlling interests, etc.(i)

(187,372)

Balance at 31 March 2020

(144,968)

  1. The Group recognised a financial liability at the present value of the expected future payment for the acquisition of additional shares of the joint venture which was established in this fiscal year based on the contract with the non-controlling shareholder.

- 74 -

21. Financial instruments

(1) Capital risk management

The Group manages its capital for continuous growth and to maximise the corporate value of the Group.

The net debt and equity of the Group are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S.

Dollars (Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Interest-bearing debt

2,838

21,966

201,834

Less: Cash and cash equivalents

293,397

317,982

2,921,820

Net debt

(290,559)

(296,016)

(2,719,986)

Equity

627,707

629,265

5,782,090

In order to maximise the corporate value of the Group, cash flows have been a priority of the Group management. As at 31 March 2019 and 2020, the Group maintained cash and cash equivalent balances in excess of interest-bearing debt balances. The Group is not subject to any externally imposed capital regulations as at 31 March 2020.

Details of interest-bearing debt and equity are described in Note 16 "Interest-bearing debt" and Note 20 "Share capital and other equity items", respectively.

(2) Significant accounting policies

Accounting policies and criteria for recognition of financial assets, financial liabilities, basis of measurement and recognition of income and expenses are described in Note 3 "Significant accounting policies".

- 75 -

(3) Categories of financial instruments

(Millions of Yen)

(Millions of Yen)

(Thousands of

U.S. Dollars (Note 2))

As at

As at

As at

31 March 2019

31 March 2020

31 March 2020

Financial assets

Financial assets measured at amortised cost

Trade and other receivables

110,847

103,339

949,547

Other financial assets (ii)

17,370

16,490

151,518

FVTOCI financial assets (iv)

Other financial assets (ii)

29,863

30,789

282,906

Cash and cash equivalents

293,397

317,982

2,921,820

Financial liabilities

FVTPL financial liabilities (v)

Trade and other payables

1,186

3,460

31,792

Other financial liabilities (iii)

3,082

542

4,976

Financial liabilities measured at amortised cost

Trade and other payables

53,701

59,435

546,131

Interest-bearing debt

2,838

21,966

201,834

Other financial liabilities (iii)

8,500

26,205

240,785

Note:

  1. The items above are not included in discontinued operations and disposal groups held for sale. The Group does not have derivative instruments designated as hedging instruments. Likewise, the Group does not have financial assets or financial liabilities using the fair value option.
  2. Other financial assets are included in 'Long-term financial assets' or 'Other short-term financial assets' in the consolidated statement of financial position.
  3. Other financial liabilities are included in 'Other long-term/short-term financial liabilities' in the consolidated statement of financial position.
  4. FVTOCI financial assets mainly consist of unlisted shares.
  5. FVTPL financial liabilities mainly consist of contingent considerations resulting from business combinations.
  6. Financial assets or liabilities to be offset as at 31 March 2019 and 2020, are immaterial.

(4) Financial risk management

In its operations, the Group is exposed to various financial risks. The Group undertakes risk management steps to minimise the effects of these financial risks. In an effort to manage these risks, the Group's risk management approach is to eliminate the sources of these risks or to minimise the risks that are not avoidable.

The Group does not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes. In certain cases, the Group obtains additional borrowings from financial institutions to react to temporary cash shortages or uses forward foreign exchange contracts to sustain cash flows. The above financial risks are managed by the financial department of the Group.

- 76 -

(5) Market risk management

The Group is exposed to risks arising from changes in the economic environment and financial markets. The factors of the risk relating to financial markets are fluctuation risk of foreign currency exchange rates, interest rates, and fair value of equity instruments.

  • Foreign currency risk

1) Foreign currency risk management

As the Group's businesses have expanded globally, foreign exchange fluctuations, in particular from the Thai Baht, the Euro and the U.S. dollar, have a significant impact on the Group's financial results. If the Japanese yen appreciates against these currencies, both sales and profit stated in the Japanese yen might decrease even though sales and profits stated in local currencies have increased.

The Group intends to marry major currencies the Group uses (i.e., Euro, U.S. dollar and Yen) in settlements of receivables/payables resulting from operating activities. Specifically, the subsidiaries that continuously conduct import or export transactions retain foreign currencies obtained from exports of goods for payables on imported supplies. This enables the Group to mitigate foreign currency risk. On the other hand, as the Company has multiple SBUs and conducts its own finance and dividend payments to the Company's shareholders, and the holding companies under the Company receive dividends from their subsidiaries and distribute them to the Company and/or other group companies, the Group's foreign currency-dominated balances in receivables, liabilities and/or bank deposits may not fully offset each other. This might cause significant gains or losses on foreign exchange differences when the Yen appreciates or depreciates against the U.S. dollar or the Euro, or when the Euro appreciates or depreciates against the U.S. dollar.

2) Foreign currency sensitivity analysis

The chart below shows the impact on profit and equity of a 1% appreciation of the Yen against the Thai Baht, the Euro and the U.S. dollar with the assumption that the exchange rates for other currencies are constant.

For the year ended 31 March 2019

For the year ended 31 March 2020

Average exchange rate

(Yen per each currency)

Thai Baht

3.43

3.51

Euro

128.26

120.85

U.S. dollar

110.07

108.95

Impact on profit for the year

(Millions of Yen)

Thai Baht

(227)

(202)

Euro

(9)

(50)

U.S. dollar

(414)

(325)

Impact on equity

(Millions of Yen)

Thai Baht

(353)

(294)

Euro

(330)

(380)

U.S. dollar

(649)

(581)

For the year ended 31 March 2020

Impact on profit for the year

(Thousands of U.S. Dollars (Note 2))

Thai Baht

1,858)

Euro

(458)

U.S. dollar

(2,985)

Impact on equity

(Thousands of U.S. Dollars (Note 2))

Thai Baht

(2,702)

Euro

(3,494)

U.S. dollar

(5,335)

- 77 -

Note:

Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Yen. The amounts above represent the impact on the consolidated financial statements of the Group resulting from foreign currency conversion and not the impact on the Group's cash flows or operations themselves.

Likewise, the tables below show the impact of a 1% appreciation of functional currencies of the Company and its holding company within the Group on their receivables/liabilities and bank deposits denominated in foreign currencies on the assumption that exchange rates for other currencies are constant. The information about the holding companies with immaterial risk is not included in the tables below.

2)-1. Parent company (the Company)

(Millions of Yen)

Euro

U.S. dollar

31 March 2019

31 March 2020

31 March 2019

31 March 2020

Trade and other receivables

(26)

(28)

(70)

(74)

Trade and other payables

2

1

10

13

Short-term financial assets

(0)

(0)

(0)

(0)

Short-terminterest-bearing debt

128

Cash and cash equivalents

(12)

(3)

(108)

(51)

Total

(36)

(29)

(40)

(113)

(Thousands of U.S. Dollars (Note 2))

Euro

U.S. dollar

31 March 2020

31 March 2020

Trade and other receivables

(254)

(681)

Trade and other payables

14

116

Short-term financial assets

(0)

(1)

Short-terminterest-bearing debt

Cash and cash equivalents

(25)

(472)

Total

(265)

(1,038)

Note:

Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Yen. A 1% depreciation of the Yen has a positive impact in the same amount.

Intercompany receivables/payables are included in the calculation of the impact as they cause foreign exchange gain or loss in the process of translation.

2)-2. Holding company (Europe)

(Millions of Yen)

Yen

U.S. dollar

31 March 2019

31 March 2020

31 March 2019

31 March 2020

Cash and cash equivalents

(3)

(0)

(1)

(35)

Total

(3)

(0)

(1)

(35)

- 78 -

(Thousands of U.S. Dollars (Note 2))

Yen

U.S. dollar

31 March 2020

31 March 2020

Cash and cash equivalents

(0)

(318)

Total

(0)

(318)

Note:

Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Euro. A 1% depreciation of the Euro has a positive impact in the same amount.

Intercompany receivables/payables are included in the calculation of the impact as they cause foreign exchange gain or loss in the process of translation.

3) Currency derivatives

The Group's policy prohibits the use of derivative instruments such as forward foreign exchange contracts, except in certain circumstances in which the use of such derivatives is determined to be beneficial. In such case, the Group can enter into contracts upon obtaining formal approval from the Chief Financial Officer ("CFO") of the Group in accordance with its Group headquarters approval process.

In order to economically hedge foreign currency exposures on intercompany receivables, payables and dividends, forward foreign exchange contracts are occasionally entered into. In these cases, the same approval policy as that stated above is adhered to.

Details of the forward foreign exchange contracts at the end of each reporting period are as follows:

(Millions of Yen)

For the year ended

Average

Foreign

Notional

Fair value

31 March 2019

exchange rate currency (mil)

amount

Forward foreign exchange contracts

N/A

(Millions of Yen)

(Thousands of U.S. Dollars (Note 2))

For the year ended

Average

Foreign

Notional

Fair value

Notional

Fair value

31 March 2020

exchange rate currency (mil)

amount

amount

Forward foreign exchange contracts

N/A

- 79 -

  • Interest rate risk management

The majority of the interest-bearing debt consists of bonds with fixed interest rates. The Group's cash and cash equivalents exceed the interest-bearing debt, and currently, the impact of interest expense on the Group's profit/loss is immaterial. Therefore, the Group considers the interest rate risk to be immaterial and has not performed sensitivity analyses such as Basis Point Value.

  • Price risks management in equity instruments

The Group is exposed to equity price risks arising from equity instruments (i.e., listed shares). These investments are held from a viewpoint of business strategy, not for short-term trading purposes. The Group does not sell these investments frequently and the Group periodically reviews the fair value of these instruments as well as the financial condition of investees.

The sensitivity analysis has been based on the exposure to the price of equity instruments (listed shares) at the end of the reporting period. If equity prices increase or decrease by 5%, accumulated other comprehensive income (pre-tax) would change by 75 million yen and 51 million yen (463 thousand U.S. dollars) as at 31 March 2019 and 2020, respectively, as a result of changes in fair value of the equity instruments.

- 80 -

(6) Credit risk management

Credit risk is the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the Group. The Group manages its credit risk by setting credit limits that are approved by the authorised personnel of each SBU.

The main customers for the Information Technology business are globalised companies that have relatively large-scale and stable financial conditions. On the other hand, credit losses were incurred on a sporadic basis in the Life Care business as those products were sold to relatively small and diversified customers, such as end consumers, retailers, and medical institutions. Accordingly, no significant credit losses were incurred in the past. A division in the Life Care business that sells goods to medical institutions and operates wholesale businesses in certain countries has some past-due receivables due to the financial conditions of those medical institutions or customers. Credit limits have been set for those customers to minimise the loss from a failure to collect the receivables.

Trade receivables consist of a large number of customers across a diverse range of industries and geographical areas. The Group has neither significant credit risk exposure for a specific customer or customer group categorised by similarity, nor concentration of credit risk over 5% of total financial assets as at 31 March 2020.

The carrying amounts after impairment presented in the consolidated financial statements are the maximum exposure for the Group's credit risk without considering the appraised value of the related collateral.

The Group continuously monitors the financial status of customers that appear to represent a credit risk in collecting receivables, including restructured receivables. Based on this monitoring, the Group sets the allowance for doubtful accounts considering the collectability of the receivables.

Each financial asset should be recognised as a credit-impaired financial asset if the debtor claims legal proceedings such as bankruptcy, company reorganization, civil rehabilitation and special liquidation in cases of overdue payments despite performance by enforcement. The Group directly writes off an asset by reducing the total carrying amount in cases where collection of contractual cashflow is not reasonably expected, entirely or partially.

- 81 -

Impaired or past-due financial assets

The following table provides the ageing details of the financial assets not yet due and the financial assets past-due but not impaired at the end of the reporting period:

(Millions of Yen)

Balance at 31 March 2019

Within due

Overdue amounts

Total

Within 30

91 to 120

Over 120

date

31 to 60 days 61 to 90 days

days

days

days

Trade and other receivables

(gross)

113,908

97,373

8,185

2,742

1,035

647

3,926

Allowance for doubtful accounts

(3,061)

(431)

(76)

(99)

(89)

(253)

(2,114)

Trade and other receivables (net)

110,847

96,942

8,109

2,643

946

394

1,812

Other financial assets (gross)

18,099

17,309

1

5

78

130

575

Allowance for doubtful accounts

(729)

(2)

(5)

(78)

(130)

(513)

Other financial assets (net)

17,370

17,307

1

61

(Millions of Yen)

Balance at 31 March 2020

Within due

Overdue amounts

Total

Within 30

91 to 120

Over 120

date

31 to 60 days 61 to 90 days

days

days

days

Trade and other receivables

(gross)

106,194

89,830

7,709

2,482

1,099

1,077

3,997

Allowance for doubtful accounts

(2,855)

(518)

(154)

(135)

(105)

(262)

(1,682)

Trade and other receivables (net)

103,339

89,312

7,555

2,347

994

815

2,316

Other financial assets (gross)

1

16,889

16,449

439

Allowance for doubtful accounts

(399)

(2)

(1)

(396)

Other financial assets (net)

16,490

16,447

43

(Thousands of U.S. Dollars (Note 2))

Balance at 31 March 2020

Within due

Overdue amounts

Total

Within 30

91 to 120

Over 120

date

31 to 60 days 61 to 90 days

days

days

days

Trade and other receivables

(gross)

975,783

825,418

70,834

22,808

10,102

9,892

36,729

Allowance for doubtful accounts

(26,235)

(4,759)

(1,413)

(1,239)

(966)

(2,406)

(15,453)

Trade and other receivables (net)

949,547

820,658

69,422

21,569

9,136

7,486

21,276

Other financial assets (gross)

155,188

151,143

13

4,032

Allowance for doubtful accounts

(3,670)

(19)

(13)

(3,638)

Other financial assets (net)

151,518

151,124

394

The Group does not hold any collateral or other credit enhancements on the above financial assets, excluding the following: As at 31 March 2019

Current portion of long-term loans to subsidiaries and affiliates of 8,248 million yen As at 31 March 2020

Long-term loans to subsidiaries and affiliates of 8,454 million yen (77,685 thousand U.S. dollars) Details of collaterals are described in Note 30 "Related party disclosures".

- 82 -

In case of impairment of financial assets, the Group does not directly write off such assets by reducing the carrying amount; instead, it records an allowance for doubtful accounts. Movement in the allowance for doubtful accounts is as follows:

Balance at 1 April 2018 Provision for the year

Reduction resulting from settlement for the year Reduction for the year (reversal)

Other (foreign exchange translation gains or losses, etc. Balance at 31 March 2019

Loss allowance at an amount equal to 12- month expected credit losses

Loss allowance at an amount equal to 12- month expected credit losses

(Millions of Yen)

Loss allowance at an amount equal to

Total

lifetime expected credit losses

Non-credit-

Credit-

Trade and

impaired

impaired

other

financial

financial

receivables

assets

assets

258

316

2,970

3,544

246

636

882

(3)

(6)

(254)

(264)

(25)

(45)

(145)

(215)

(11)

(1)

(145)

(157)

219

509

3,061

3,790

(Millions of Yen)

Loss allowance at an amount equal to

Total

lifetime expected credit losses

Non-credit-

Credit-

Trade and

impaired

impaired

other

financial

financial

receivables

assets

assets

Balance at 1 April 2019

Provision for the year

Reduction resulting from settlement for the year

Reduction for the year (reversal)

Other (foreign exchange translation gains or losses, etc.

Balance at 31 March 2020

Loss

allowance at

an amount

equal to 12-

month

expected

credit losses

Balance at 1 April 2019

Provision for the year

Reduction resulting from settlement for the year

Reduction for the year (reversal)

Other (foreign exchange translation gains or losses, etc.

Balance at 31 March 2020

219

509

3,061

3,790

6

626

632

(185)

(70)

(495)

(751)

(70)

(133)

(203)

(7)

(3)

(203)

(214)

27

372

2,855

3,255

(Thousands of U.S. Dollars (Note 2))

Loss allowance at an amount equal to Total lifetime expected credit losses

Non-credit-

Credit-

Trade and

impaired

impaired

other

financial

financial

receivables

assets

assets

2,015

4,679

28,126

34,821

58

5,754

5,812

(1,701)

(646)

(4,549)

(6,896)

(640)

(1,226)

(1,866)

(63)

(31)

(1,869)

(1,964)

251

3,420

26,235

29,906

- 83 -

(7) Liquidity risk management

The ultimate responsibility for liquidity risk management rests with the CFO of the Group who is appointed by the board of directors. Based on the instructions from the CFO, the financial headquarters of the Group mainly manages the Group's liquidity risk by maintaining an appropriate level of retained earnings and credit facilities, and monitors the actual cash flows and forecasted cash flows. The credit lines for commercial paper are secured for temporary cash shortages due to dividends or bonus payments.

The following table details the contractual maturity of its financial liabilities, including derivative financial instruments but excluding guarantee liabilities:

(Millions of Yen)

Balance at 31 March 2019

Carrying

Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5

amount

cash flows

year

years

Non-derivative liabilities

Trade and other payables

54,887

54,887

54,887

Long-term bank loans (excluding

327

327

52

19

19

19

216

current portion)

Current portion of long-term bank

1

1

1

loans

Short-term bank loans

1,648

1,648

1,648

Long-term lease obligations

577

577

259

187

105

26

Short-term lease obligations

285

285

285

Other financial liabilities

11,582

11,582

646

8,875

1,933

129

Total

69,308

69,308

57,467

9,186

2,139

254

46

216

(Millions of Yen)

Balance at 31 March 2020

Carrying

Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5

amount

cash flows

year

years

Non-derivative liabilities

Trade and other payables

62,895

62,895

62,895

Long-term bank loans (excluding

234

234

38

19

19

19

140

current portion)

Current portion of long-term bank

19

19

19

loans

Short-term bank loans

864

864

864

Long-term lease obligations

14,237

14,909

5,170

3,398

2,169

1,309

2,863

Short-term lease obligations

6,610

6,610

6,610

Other financial liabilities

26,746

29,709

2,824

2,922

522

4,125

19,318

Total

111,607

115,242

73,212

8,129

3,939

6,312

1,328

22,321

- 84 -

(Thousands of U.S. Dollars (Note 2))

Balance at 31 March 2020

Carrying

Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5

amount

cash flows

year

years

Non-derivative liabilities

Trade and other payables

577,922

577,922

577,922

Long-term bank loans (excluding

2,154

2,154

347

172

172

172

1,288

current portion)

Current portion of long-term bank

175

175

175

loans

Short-term bank loans

7,941

7,941

7,941

Long-term lease obligations

130,823

136,992

47,501

31,227

19,928

12,028

26,308

Short-term lease obligations

60,741

60,741

60,741

Other financial liabilities

245,761

272,989

25,944

26,846

4,796

37,900

177,502

Total

1,025,517

1,058,914

672,723

74,694

36,196

58,000

12,199

205,098

Note:

Guarantee liabilities have been excluded from the above table as the likelihood of execution has been determined as low.

The Company secures the financing methods below for temporary cash shortages due to dividends or bonus payments. Details of financing methods and status are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Bank overdraft

Used

Unused

65,000

65,000

597,262

Total

65,000

65,000

597,262

Commercial paper

Used

Unused

50,000

50,000

459,432

Total

50,000

50,000

459,432

- 85 -

(8) Fair value of financial assets and liabilities that are measured at fair value on a recurring basis

The following table provides an analysis of financial instruments that have been measured at fair value subsequent to initial recognition.

The fair values are categorised into Levels 1 to 3.

Level 1: Fair value derived from quoted prices in active markets for identical assets or liabilities.

Level 2: Fair value derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).

Level 3: Fair value derived from inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).

    • FVTOCI financial assets classified as Level 3 mainly consist of unlisted shares and are measured using valuation techniques such as net asset approach, discount cash flow method or comparable company method.
    • FVTPL financial liabilities classified as Level 3 consist of contingent considerations and are measured based on the achievement of milestones considering time value of money.
  • Financial instruments that are measured at fair value

(Millions of Yen)

As at 31 March 2019

Level 1

Level 2

Level 3

Total

FVTOCI financial assets

1,499

28,364

29,863

Total

1,499

28,364

29,863

FVTPL financial liabilities

4,268

4,268

Total

4,268

4,268

(Millions of Yen)

As at 31 March 2020

Level 1

Level 2

Level 3

Total

FVTOCI financial assets

1,028

29,761

30,789

Total

1,028

29,761

30,789

FVTPL financial liabilities

4,001

4,001

Total

4,001

4,001

(Thousands of U.S. Dollars (Note 2))

As at 31 March 2020

Level 1

Level 2

Level 3

Total

FVTOCI financial assets

9,444

273,462

282,906

Total

9,444

273,462

282,906

FVTPL financial liabilities

36,768

36,768

Total

36,768

36,768

Note:

As at 31 March 2019

No transfers occurred between Levels 1, 2 and 3 during the year ended 31 March 2019.

As at 31 March 2020

No transfers occurred between Levels 1, 2 and 3 during the year ended 31 March 2020.

- 86 -

  • Reconciliation of financial assets categorised at Level 3 from beginning balance to ending balance

(Millions of Yen)

For the year ended

Fair value measurement as at the end of the reporting period

31 March 2019

Available-for-sale financial assets

FVTPL financial liabilities

618

4,289

Opening balance

Total gains or losses recognised:

382

(165)

- in profit or loss (i)

(277)

- in other comprehensive income (i)

382

112

Purchase(ii)

27,376

Increase

234

Sale

(11)

Settlement

(89)

Closing balance

28,364

4,268

(Millions of Yen)

For the year ended

Fair value measurement as at the end of the reporting period

31 March 2020

FVTOCI financial assets

FVTPL financial liabilities

28,364

4,268

Opening balance

Total gains or losses recognised:

1,753

3

- in profit or loss (i)

96

- in other comprehensive income (i)

1,753

(92)

Purchase

0

Increase

20

Sale

(357)

Settlement

(289)

Closing balance

29,761

4,001

(Thousands of U.S. Dollars (Note 2))

For the year ended

Fair value measurement as at the end of the reporting period

31 March 2020

FVTOCI financial assets

FVTPL financial liabilities

260,630

39,218

Opening balance

Total gains or losses recognised:

16,110

30

- in profit or loss (i)

878

- in other comprehensive income (i)

16,110

(848)

Purchase

3

Increase

180

Sale

(3,280)

Settlement

(2,660)

Closing balance

273,462

36,768

Note:

As at 31 March 2019

  1. Total gains or losses included in profit or loss are included in the line item 'Other income' or 'Finance costs' in the consolidated statement of comprehensive income.
    In total gains or losses included in other comprehensive income, gains or losses related to FVTOCI assets are included in
    'Financial assets measured at fair value through other comprehensive income' or 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income. Gains or losses related to FVTPL liabilities are included in 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income.
  2. On 1 June 2018, the Group invested 27,000 million yen in K.K. Pangea (KIOXIA Holdings Corporation).

- 87 -

As at 31 March 2020

  1. Total gains or losses included in profit or loss are included in the line item 'Finance costs' in the consolidated statement of comprehensive income.
    In total gains or losses included in other comprehensive income, gains or losses related to FVTOCI assets are included in 'Financial assets measured at fair value through other comprehensive income' or 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income. Gains or losses related to FVTPL liabilities are included in 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income.

- 88 -

(9) Fair value of financial assets and liabilities that are measured at fair value on a non-recurring

basis

  • Carrying amounts and fair value

Assets

Financial assets measured at amortised cost Long-term loans to subsidiaries and affiliates Lease deposits

Total

Liabilities

Financial liabilities measured at amortised cost Long-term bank loans (excluding current portion)

Long-term guarantee deposits Total

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Carrying

Fair value

Carrying

Fair value

Carrying

Fair value

amount

amount

amount

8,248

8,742

80,331

8,676

8,454

77,685

5,100

5,100

5,304

5,304

48,736

48,736

13,348

13,775

13,758

14,046

126,421

129,067

327

368

234

243

2,154

2,237

7,855

7,665

2,989

2,974

27,469

27,331

8,183

8,035

3,224

3,217

29,622

29,568

- 89 -

  • Fair value hierarchy

Level 1: Fair value derived from quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Fair value derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).

  • Fair value of long-term loans to subsidiaries and affiliates and lease deposits are measured by the present value of future cash flows of each loan categorised according to a certain range of term and discounted by the risk-free rate, etc.
  • Fair value of interest-bearing debt other than bonds is measured by the present value of future cash flows of each debt categorised according to a certain range of term, and discounted by the interest rate that reflects the remaining period to the maturity and credit risk.

Level 3: Fair value derived from inputs for the asset or liability that are not based on observable market data (unobservable inputs).

(Millions of Yen)

As at 31 March 2019

Level 1

Level 2

Level 3

Total

Assets

Loans and receivables

Long-term loans to subsidiaries and affiliates

8,676

8,676

Lease deposits

5,100

5,100

Total

13,775

13,775

Liabilities

Financial liabilities measured at amortised cost

Long-term bank loans (excluding current portion)

368

368

Long-term guarantee deposits

7,665

7,665

Total

8,033

8,033

(Millions of Yen)

As at 31 March 2020

Level 1

Level 2

Level 3

Total

Assets

Financial assets measured at amortised cost

Long-term loans to subsidiaries and affiliates

8,742

8,742

Lease deposits

5,304

5,304

Total

14,046

14,046

Liabilities

Financial liabilities measured at amortised cost

Long-term bank loans (excluding current portion)

243

243

Long-term guarantee deposits

2,974

2,974

Total

3,217

3,217

(Thousands of U.S. Dollars (Note 2))

As at 31 March 2020

Level 1

Level 2

Level 3

Total

Assets

Financial assets measured at amortised cost

Long-term loans to subsidiaries and affiliates

80,331

80,331

Lease deposits

48,736

48,736

Total

129,067

129,067

Liabilities

Financial liabilities measured at amortised cost

Long-term bank loans (excluding current portion)

2,237

2,237

Long-term guarantee deposits

27,331

27,331

Total

29,568

29,568

- 90 -

22. Share-based payments

The Company has a performance-based stock compensation plan (Performance Share Unit) and a stock option plan. The purpose of the plans is to increase the value of the Group and to improve the financial results of the Group by motivating members such as directors, officers, employees of the Group, as well as to retain valuable employees.

  1. Performance Share Unit
    Details of transactions
    The Company has adopted Performance Share Unit (PSU) for officers instead of a stock option plan since the year ended 31 March 2020. The variable number of shares will be distributed to the granted officers based on the achievement of pre-determined performance goal during the three years subsequent to the grant date. The number of distributed shares is variable from 0% to 200% based on the achievement of the performance goal that consists of consolidated sales, earnings per share (EPS) and ROE.
    PSU granted to officers are accounted for as cash-settledshare-based payment transactions. Expense recorded in the consolidated statement of comprehensive income from undertaking shared-based payment transactions was 31 million yen (286 thousand U.S. dollars) for the year ended 31 March 2020.

Details of PSU that are outstanding for the year ended 31 March 2020, are as follows:

No. Number of shares Grant date Fair value at grant date (Yen)

1

15,500

1 Jul 2019

8,045

  • Determination of fair value

The fair value of the PSU granted during the years ended 31 March 2020, was 8,045 yen and was determined based on the share price of the grant day.

  1. Stock Option Plan
    Details of transactions
    After the details and eligible members are approved at the meeting of the board of directors, options are granted to individuals on the condition that they render services over the vesting period, that is, subsequent to the grant date, if a member terminates his or her employment prior to the vesting date, the options will expire. The exercise period of the options is the period determined in each option contract. The options not exercised within this exercise period will expire. The option contract includes a clause that limits the maximum number of stock options a member can exercise each year during the exercisable periods.

Stock options granted to members are accounted for as share-settledshare-based payment transactions. Expense recorded in the consolidated statement of comprehensive income from undertaking shared-based payment transactions was 195 million yen and 125 million yen (1,153 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.

Details of the stock options that are outstanding for the years ended 31 March 2019 and 2020, are as follows:

No.

Number of shares

Grant date

Expiry date

Exercise price (Yen)

Fair value at grant date

(Yen)

10

8 Dec 2009

30 Sep 2019

2,215

2,784

1,247,600

11

1,225,600

7 Dec 2010

30 Sep 2020

1,947

1,861

12

680,800

17 Jan 2012

30 Sep 2021

1,616

1,427

13

560,800

16 Jan 2013

30 Sep 2022

1,648

1,707

14

758,800

15 Jan 2014

30 Sep 2023

2,846

3,141

15

582,400

14 Jan 2015

30 Sep 2024

3,972.5

3,585

16

460,400

13 Jan 2016

30 Sep 2025

4,928

3,407

17

386,800

17 Jan 2017

30 Sep 2026

4,839

3,740

18

40,400

13 Feb 2018

30 Sep 2027

5,765

4,009

19

123,600

2 Oct 2018

30 Sep 2028

6,590

6,345

20

20,000

13 Aug 2019

30 Sep 2029

8,542

7,645

- 91 -

  • Determination of stock option value

The weighted-average fair value of the stock options granted during the years ended 31 March 2019 and 2020, was 6,345 yen and 7,645 yen, respectively.

In determining the expense of the stock options, the options were priced using the Black-Scholes model. The following table details the assumptions used in the Black-Scholes model for the options granted in the years ended 31 March 2019 and 2020.

Expected volatility was determined based on recent historical daily share price volatility from the grant date to the forecasted remaining period.

No. 19

No. 20

Share price at grant date (Yen)

6,855

8,515

Exercise price (Yen)

6,590

8,542

Expected volatility

26.46%

27.69%

Expected remaining option life (Years)

6.2

6.4

Dividends yield

1.09

1.06

Risk free rate

(0.01%)

(0.35%)

- 92 -

(3) The number and weighted-average exercise prices of stock options

The weighted-average exercise price of the outstanding options was 3,911 yen and 4,078 yen as at the years ended 31 March 2019 and 2020, respectively. Weighted-average remaining contractual life was 5.4 years and 4.8 years as at 31 March 2019 and 2020, respectively.

For the year ended 31 March 2019

For the year ended 31 March 2020

Weighted-average

Weighted-average

Number of shares

exercise price

Number of shares

exercise price

(Yen)

(Yen)

Outstanding at the beginning of the period

1,924,400

3,604

1,510,000

3,911

Granted

123,600

6,590

20,000

8,542

Forfeited (i)

(41,600)

4,279

(31,200)

5,184

Exercised

(453,600)

3,527

(328,400)

3,888

Expired

(42,800)

1,556

(72,400)

2,215

Outstanding at the end of the period

1,510,000

3,911

1,098,000

4,078

Exercisable at the end of the period

1,086,400

3,316

890,600

3,623

Note:

(i) Stock options forfeited were due to employee retirements.

Stock options exercised during the year ended 31 March 2020, were as follows:

No.

Number of shares exercised

Exercise period

Weighted-average of share price at

exercise date (Yen)

10

16,400

April 2019 to September 2019

7,936

11

25,600

April 2019 to February 2020

8,181

12

23,600

April 2019 to February 2020

8,080

13

13,200

May 2019 to February 2020

8,393

14

34,000

April 2019 to March 2020

8,093

15

44,000

April 2019 to January 2020

8,074

16

101,200

April 2019 to March 2020

8,077

17

54,800

April 2019 to January 2020

8,039

18

9,200

May 2019 to November 2019

8,169

19

6,400

November 2019 to February 2020

8,730

Total

328,400

Note:

The number of shares exercised and the amount paid by key management personnel are 80,000 shares and 286 million yen, respectively.

Stock options exercised during the year ended 31 March 2019, were as follows:

No.

Number of shares exercised

Exercise period

Weighted-average of share price at

exercise date (Yen)

8

13,600

July 2018 to September 2018

6,216

10

42,800

April 2018 to February 2019

6,176

11

5,200

June 2018 to November 2018

6,173

12

19,600

August 2018 to February 2019

6,282

13

11,200

May 2018 to March 2019

6,272

14

112,400

April 2018 to March 2019

6,194

15

128,800

April 2018 to February 2019

6,381

16

67,600

June 2018 to February 2019

6,259

17

46,800

June 2018 to March 2019

6,309

18

5,600

October 2018 to November 2018

6,310

Total

453,600

Note:

The number of shares exercised and the amount paid by key management personnel are 154,400 shares and 565 million yen, respectively.

- 93 -

23. Revenue

(1) Disaggregation of revenue

The relationship between the major geographical areas and the Group's revenue from continuing operations from its major products and services for the year ended 31 March 2019 and 2020 is as follows:

(Millions of Yen)

For the year ended 31 March 2019

Japan

Asia

Americas

Europe

Others

Total

Life Care

Health Care related products

109,824

28,937

67,842

70,239

4,771

281,613

Medical related products

19,335

13,154

21,029

35,394

2,864

91,775

Life Care total

129,159

42,090

88,871

105,633

7,635

373,388

Information Technology

Electronics related products

20,606

114,649

9,155

2,212

0

146,623

Imaging related products

11,286

28,624

598

415

1

40,924

Information Technology total

31,892

143,273

9,753

2,627

1

187,546

Other

2,770

595

494

1,016

4,875

Total revenue from external

163,821

185,959

99,118

109,277

7,636

565,810

customers

(Millions of Yen)

For the year ended 31 March 2020

Japan

Asia

Americas

Europe

Others

Total

Life Care

Health Care related products

113,541

27,109

64,516

68,392

4,240

277,798

Medical related products

20,647

13,525

22,160

37,819

3,101

97,251

Life Care total

134,188

40,633

86,676

106,210

7,341

375,049

Information Technology

Electronics related products

17,068

134,515

9,002

2,071

1

162,655

Imaging related products

8,845

23,696

937

597

1

34,076

Information Technology total

25,913

158,211

9,939

2,667

1

196,731

Other

2,944

561

579

683

-

4,766

Total revenue from external

163,045

199,405

97,194

109,561

7,343

576,546

customers

(Thousands of U.S. Dollars (Note 2))

For the year ended 31 March 2020

Japan

Asia

Americas

Europe

Others

Total

Life Care

Health Care related products

1,043,289

249,092

592,819

628,425

38,961

2,552,586

Medical related products

189,715

124,273

203,620

347,501

28,495

893,605

Life Care total

1,233,004

373,365

796,439

975,926

67,457

3,446,191

Information Technology

Electronics related products

156,831

1,236,006

82,712

19,025

5

1,494,580

Imaging related products

81,275

217,734

8,612

5,483

6

313,109

Information Technology total

238,106

1,453,740

91,324

24,509

11

1,807,690

Other

27,048

5,152

5,318

6,278

-

43,797

Total revenue from external

1,498,158

1,832,258

893,081

1,006,713

67,468

5,297,677

customers

Note:

Geographical areas are based on the location of the customers.

- 94 -

(2) Contract balances

Receivables from contracts with customers and contract liabilities are as follows. Contract liabilities consist mainly of advance received from customers.

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

As at 31 March 2019

As at 31 March 2020

As at 31 March 2020

Receivables from contracts

108,152

100,262

921,267

with customers

Contract liabilities

4,011

2,904

26,681

Note:

Revenues recognised in the years ended 31 March 2019 and 2020 that were included in the contract liability balances as at 1 April 2019 and 2020 were 2,401 million yen and 1,710 million yen (15,717 thousand U.S. dollars), respectively.

(3) Transaction price allocated to the remaining performance obligations

The Group uses the practical expedient of omitting the disclosure of information on the remaining performance obligations because it has no significant transactions with individual expected contractual terms exceeding one year. In addition, no significant financing components are included in consideration from contracts with customers.

(4) Assets recognised from the costs to obtain a contract with a customer

If the amortisation period of the assets is one year or less, the Group uses the practical expedient of recognising the incremental costs of obtaining the contract as an expense when incurred.

- 95 -

- 96 -
Employee benefits expense Depreciation and amortisation Commission expenses
Other expenses Total R&D expenses recognised as incurred
Note:
The above items are included in the corresponding line items in the consolidated statement of comprehensive income.
For the year ended
31 March 2019
9,551
2,023
3,445
11,081
26,100
For the year ended
31 March 2020
10,053
2,743
3,423
10,633
26,851
(Thousands of U.S. Dollars
(Note 2))
For the year ended
31 March 2020
92,376
25,200
31,454
97,699
246,729
(Millions of Yen)
(Millions of Yen)
(2) R&D expenses recognised as incurred
(Thousands of U.S. Dollars
(Note 2))
For the year ended
31 March 2020
3,465
1,199
3,885
4,021
845
9,213
22,627

24. Revenue and expenses (excluding finance income and costs)

(1) Other income from continuing operations

The following is an analysis of the Group's other income from continuing operations:

(Millions of Yen)

(Millions of Yen)

For the year ended

For the year ended

31 March 2019

31 March 2020

Commission

320

377

Rent

121

130

Government grants

398

423

Gain on sale of plant, property and equipment

and intangible assets

674

438

Insurance proceeds

35

92

Others

2,227

1,003

Total other income

3,775

2,463

(3) Employee benefits expense

The following is an analysis of the Group's employee benefits expense from continuing operations:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Salary, bonuses and others

121,016

122,370

1,124,417

Retirement benefit

Defined benefit

626

918

8,439

Defined contribution

2,416

2,371

21,787

Retirement benefit total

3,043

3,290

30,226

Share-based payments (stock option)

195

157

1,439

Severance payments

1,924

1,770

16,264

Others

5,829

6,147

56,487

Total employee benefits expense

132,006

133,734

1,228,834

(4) Foreign exchange gains or losses

Foreign exchange gains or losses include gains resulting from changes in fair value of currency derivatives.

(5) Other expenses

The following is an analysis of the Group's other expenses from continuing operations:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Packaging/shipping/transportation

11,268

11,318

103,999

Travel

6,647

6,596

60,611

Rent

8,056

Utilities

12,160

11,928

109,600

Repair and maintenance

13,378

13,185

121,152

Loss on sales of property, plant and equipment

182

180

1,654

Loss on disposal of property, plant and

equipment

609

375

3,444

Others (Note)

75,710

74,186

681,667

Total other expenses

128,010

117,768

1,082,127

Note:

In April 2015, the U.S. Department of Justice issued a subpoena to Pentax of America, Inc. ("Pentax"), a U.S. subsidiary of the Company. The subpoena sought information with respect to duodenoscopes that Pentax and its affiliated companies manufactured and sold. The Company and Pentax cooperated with the U.S. Department of Justice ("DOJ") and responded to its requests. In April 2020, the Company and Pentax finalised a Deferred Prosecution Agreement with DOJ and the Group recorded an accrual for a fine and forfeiture totaling 4,680 million yen (43,000 thousand U.S. dollars).

- 97 -

25. Finance income and costs

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Finance income

Interest income

Cash and cash equivalents, financial

assets measured at amortized cost

2,763

3,452

31,715

Dividend income

FVTOCI financial assets

10

10

92

Total finance income

2,733

3,461

31,806

Finance costs

Interest costs

Interest-bearing debt

76

431

3,963

Retirement benefits liabilities

36

47

432

Provisions

18

18

164

Other liabilities

262

116

1,065

Impairment losses

Financial assets measured at amortised

cost

178

1,639

Total finance costs

391

791

7,264

- 98 -

26. Other comprehensive income

For the years ended 31 March 2019 and 2020, items that may be reclassified subsequently to profit or loss comprise the following:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Items that may be reclassified subsequently

to profit or loss:

Exchange differences on translation of

foreign operations (i)

Gains (losses) arising during the year

7,059

(17,072)

(156,868)

Reclassification adjustments to profit or

loss for the year

(447)

266

2,447

Total

6,612

(16,806)

(154,420)

  • Share of other comprehensive income of

associates

Gains (losses) arising during the year

(17)

76

701

Reclassification adjustments to profit or

loss for the year

0

Total

(16)

76

701

Other comprehensive income/(loss) before

tax

6,596

(16,729)

(153,719)

Income tax relating to components of other

comprehensive income

124

(203)

(1,863)

Total other comprehensive income/(loss)

(net of tax)

6,720

(16,932)

(155,583)

Note:

  1. 'Exchange differences on translation of foreign operations' consist of differences on foreign currency conversion for financial statements of foreign operations.

- 99 -

Deferred and current taxes on each item of other comprehensive income for the years ended 31 March 2019 and 2020, are as follows:

(Millions of Yen)

(Millions of Yen)

(Thousands of U.S. Dollars

(Note 2))

For the year ended

For the year ended

For the year ended

31 March 2019

31 March 2020

31 March 2020

Total

Tax

Net of tax

Total

Tax

Net of tax

Total

Tax

Net of tax

Other comprehensive

income attributable to

owners of the Company

FVTOCI financial assets

839

(142)

697

949

(234)

715

8,720

(2,149)

6,571

Exchange differences on

translation of foreign

operations

6,729

124

6,853

(16,602)

(203)

(16,805)

(152,552)

(1,863)

(154,415)

Remeasurements of the

net defined benefit

liability (asset)

(293)

(10)

(303)

(50)

22

(29)

(463)

200

(263)

Share of other

comprehensive income

of associates

(16)

(16)

76

76

701

701

Subtotal

7,259

(28)

7,231

(15,627)

(415)

(16,042)

(143,593)

(3,812)

(147,406)

Other comprehensive

income attributable to non

-controlling interests

FVTOCI financial assets

(30)

7

(23)

(16)

(16)

(150)

(150)

Exchange differences on

translation of foreign

operations

(117)

(117)

(203)

(203)

(1,869)

(1,869)

Subtotal

(147)

7

(140)

(220)

(220)

(2,019)

(2,019)

Total other comprehensive

income/(loss)

7,113

(21)

7,091

(15,847)

(415)

(16,262)

(145,612)

(3,812)

(149,424)

- 100 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Hoya Corporation published this content on 11 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2020 06:04:09 UTC